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1 Introduction 
1.1 Polyphenols 
 
Polyphenols are a class of natural chemical substances that can be found in many 
vegetables. Their main chemical characteristic is the presence of multiple phenolic groups. 
Among them there are other several subclasses like flavonoids. 
Flavonoids are important secondary metabolites that can be also found in plants. Flavonoids 
are based around a phenylbenzopyrone structure [fig.1] 
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Fig. 1 phenylbenzopyrone structure 
In general plants alone possess the biosynthetic ability[1]. Flavonoid were found also in 
primitive plant species like green algae[2] and they survived through evolution. 
Flavonoids can be divided in several subclasses depending on their sustituents. Moreover 
flavonoids have other substitution patterns with addition hydroxyl, methyl, methoxyl and 
glycosil groups. 
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Fig. 2 : structures of flavonoids classes 
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The main activity of flavonoids is as antioxidant, but they have also protective function 
versus physiological regulatory mechanisms [3]. In plants flavonoids can be found in several 
components, like leaves[4], seeds[5], stems and roots[3]. 
Flavonoids are also responsible of several sensorial aspects: they are found as pigments in 
several plant components [6], and are responsible of astringency [7] and bitterness [8]. 
Flavonoids are also responsible of browning in fruit [9]. 
The antioxidant activity of flavonoids is comparable to that of other synthetic antioxidants 
like BHT and BHA. It has been postulated[10] that the mechanism of the peroxyl radical 
reaction involves a consecutive two-electron mechanism with 3’,4’- and 2’,5’-
dihydroxyflavonols to yield corresponding quinones. The first one-electron oxidation 
produces the flavonoid phenoxyl radical, which subsequently scavanges another peroxyl 
radical: 
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Fig. 3: mechanism of the peroxyl radical reaction 
One of the most important sources of flavonoids are red grape seeds[11]. In grape seeds 
flavonoids are mainly present as proanthocyanidines. Proanthocyanidines are condensed 
flavonoids responsible of red colouring in various berries and have protecting activities. They 
exhibit an higher antioxidant activity compared to other monomeric flavonoid ( i.e. catechin, 
epigallocatechin gallate). Grape Seed Extract (GSE) is one of the most used nutraceutical 
supplement of antioxidants in the market and the consumption extimated year consumption is 
1 milion kg. The great success of GSE is probably due to the so called “French Paradox”, 
where a normal consumption of red wine leads also to a low rate of cardio-vascular diseases; 
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even if this paradox has not been confirmed several studies have been conducted on possible 
benefits of GSE on human health. 
The polphenol content of seeds may range from 1% to 8% by weight [12] depending from 
several aspects[13] like the cultivar, the climatic conditions from year to year, the effect of 
geographic origin of grapes, soil chemistry and fertilization. 
The flavonoid composition of white grapes is different from that of red grapes[12] and are 
richer in catechins and their polymeric forms. White grape seeds are used for the production 
of one of the most selled GSE (Leucoselect, Indena, Milan), while other GSE producers use 
only red grape seeds. 
1.2 GSE and health 
1.2.1 Effects on myocardium and the cardiovascular system 
 
Free radicals play an important role in myocardium pathogeneses, such as ischemia and 
reperfusion. Since grape seeds extract exerts a great power in free radical’s disruption, some 
studies could also prove its effectiveness within these related fields. Instead, cardiovascular 
diseases are associated to modifications of fatty acids metabolism and to an extreme LDL 
lipidic peroxidation. These oxidation products are also involved in the tromboxane formation, 
which first of all leads to an increase in the platelet aggregation, secondly to artery obstruction 
and finally to thrombosis [14]. Possible accumulation of lipidic oxidation products coming 
from LDL, may be attributed to the low antioxidants contents in plasma. 
It clearly results (see paragraph 3.4) how polyphenols, originated from grape seeds by 
inhibiting LDL oxidation, may reduce the cardio pathologies risk. 
  
1.2.1.1 Protection against riperfusion and miocardium ischemia  
The GSE protective effect was tested during post ischemic riperfusion and after an ischemic 
cardiac arrest on laboratory mice  [15, 16]. Cavies were divided into two separate groups: to 
one group GSE was given, while for the second group, just water was supplied. After three 
weeks, on rats hearts a global ischemia was induced for 30 minutes, following a 2 hours 
riperfusion. The left ventricle functions were monitored continuously and both creatin kinase 
(CK, as an indicator of necrosis and of tissues inflammation) and malondialdehyde (MDA, as 
an oxidative stress indicator) was estimated. Besides, the entity of heart failure was measured 
through TTC. 
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From the analyses, it was possible to verify a high cardiac protecting activity of GSE: better 
post-ischemic functions of the left ventricle, a reduced CK release and a minor formation of 
MDA in coronary effluents, by comparison with the control. In addition, the myocardium 
heart failure entity of the group which received GSE, was almost 25% lower than the control. 
  
1.2.1.2 The effect on platelet aggregation 
Grape products, rich in poliphenols, are responsible for the platelet aggregation (PA) 
inhibition, a risk factor of coronaries. In vitro studies on human platelets and ex vivo research 
on dog platelets have been performed. More precisely, the extract effect was tested on 
collagen-induced whole blood PA [17]. In these studies, an interesting synergy between seeds 
extract and grape skins was highlighted. Furthermore, investigations done by Chang and 
Maffei Facino have hypothesized that GSE mechanism of action is related to the inhibitory 
effect that is exerted on B2 tromboxan biosynthesis [18, 19]. 
 
1.2.1.3 Effects on micro circulation 
Grape seeds derived procyanidines, have demonstrated to show effects on micro circulation, 
by a capillary strengthening [20, 21]. These data were obtained via double-blind analyses. 
More accurately, researchers have analyzed the vascular permeability both of brain and heart 
muscle capillaries. Their normal permeability grade was easily increased in pathological 
inflammation conditions or in case of diabetes. In laboratory, these pathologies were 
reproduced through collagenase injections. Animals pre-treated with procyanydolic 
oligomers, have considerably reduced the capillary permeability increase, induced by 
collagenase injection, with a final effect of microcirculation reinforcement. 
Further double blind studies done on patients affected by peripheral venous insufficiency 
have proved the GSE efficacy in the treatment of these pathologies [22]. 
  
1.2.1.4 Effects on blood pressure on hypertensive patients 
Research has been done on hypertensive rats feed with GSE [23]. After three weeks of 
treatment it has been evidenced a decrease in the systolic pressure, in comparison with 
controls. In this study it has been shown the greater and non synergistic effectiveness of the 
GSE with respect to other antioxidant species (chrome and zinc), which act positively in this 
kind of pathology. 
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1.2.2 Cytotoxicity 
 
1.2.2.1 Different toxicity on normal cells as regards malignant cell 
The GSE cytotoxicity has been tested on carcinogenic human cells cultures, including active 
cells in breast cancer, in gastric adenocarcinoma and in lung cancer. This has been tested via 
morphological analysis and cytotoxic test of MTT( 3-(4,5-Dimethylthiazol-2-yl-2,5-
diphenyltetrazolium bromide). These effects were compared with two normal cells, 
comprising human gastric mucous membrane and macrophages cells. The GSE has 
demonstrated a selective toxicity against the examined cancerous cells, whereas at the same 
concentration, positive effects on normal cells growth were observed [24] . 
 
1.2.2.2 Protection against citotoxicity induced by chemotherapeutical agents. 
The anticancer chemotherapeutical agents are very effective, both in vitro and in vivo, in the 
reduction of cancerous cells growth; unfortunately the inconvenience is their toxicity as 
regards normal cells. 
As an example, Idarubicin or the 4-hydroxyperoxycyclofoafammide (4-HC) are very 
effective chemotherapeutic agents, capable of inducing apoptosis to target cells. Healthy cells 
have been treated in vitro with such medicines, with or without GSE. Results have shown a 
decrease of their inhibitory effect on growth (using MTT assay) and of their cytotoxicity in 
cells treated with GSE. Besides, from flux cytometric analysis, a greater decrease by 50% has 
been found on the number of cells undergoing apoptosis [25]. 
The Doxorubicin is another anticancer medicine, whose application is strongly limited by its 
elevated cardiotoxicity. The principal in vivo target of the Doxorubicin is DNA. For this 
reason studies have been done on GSE possibility of protecting DNA from Doxorubicin 
induced damages, owing to its antioxidant properties, therefore preventing cardiotoxicity. 
Laboratory guinea pigs were fed with GSE and subsequently Doxorubicin was supplied. 
Hystopathologic analysis and investigations on DNA performed on guinea pigs heart have 
shown a protection of GSE towards damages caused by Doxorubicin, thorough a decrease of 
apoptosis and cellular necrosis, also preventing DNA damages. Such effect is almost 
equivalent to that of the 3-amminobenzammide (3-AB), a promising anticancer medicine, 
which inhibits DNA damages significantly.  
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Studies on the probable mechanism that takes part in the protection of GSE towards cellular 
damages induced by chemotherapeutic agents have shown mediation, due to alterations in 
some genes expression. More precisely, GSE increases the expression of the antioxidant gene 
bcl-2 and decreases the expression of the gene which induces the cancer c-myc and of the p53 
gene, responsible of the apoptosis regulation [25]. 
 
1.2.2.3 Anti-ornithine decarboxilase activities in animals 
Researchers working in institutes of research committed with cancer at Kansas State 
University have found that when laboratory animals are exposed to a variety of chemical 
carcinogenic agents, the production of a skin cancer type was stimulated. One of the markers 
of this cancer is the ornithine decarboxylase. It was observed that when the synthesis of this 
enzyme is chemically promoted, such event is responsible of the development of skin cancer 
in animals. When animals are fed with of GSE supplements, an inhibition of the ornithine 
decarboxylase formation was found. This prevents the formation of cancer in animals, even 
when they are deliberately exposed to chemical carcinogenic agents [26]. 
 
1.2.3 Protection against inflammation and allergy 
The polyphenols activity deriving from grapes seeds, expounds even on enzymatic systems, 
responsible for the production of free radicals, associated with inflammatory reactions. 
Furthermore, they operate during the synthesis and the release of any substances that promote 
inflammations and the onset of allergies, as for example the histamine [27-29]. 
The proanthocyanidines even inhibit the formation of hyaluronidase, an enzyme acting 
against several tissues during inflammatory processes. Its action is correlated to the 
antihistaminic effect and to the ability of strengthening the cell membranes of the basophile 
plants and the macrophages, containing allergens, hence preventing the hypersensibilization 
to polluting agents and to food allergens [30]. 
Other studies confirming the GSE anti inflammatory action (against arthritises, etc.) have 
identified a mechanism that shows the active proantocyanidines radicals as scavenger of 
oxygen, as protectors against the lipidic peroxidation of the cell membranes and as promoter 
of the inhibition of the inflammatory cytokines formation. [31]. 
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1.2.4 Antioxidant activity 
The antioxidant activity of a system is always relative to the mean in which the system 
operates. It’s widely known the antioxidant property of vitamins C and E, which are 
supplemented as such, in several commercial supplements. In nutraceutical products, the 
presence of both is justified by the fact that a combination of the two represents a more 
powerful antioxidant system than the one observed when each one is taken separately. 
In 1960, as a consequence of this effect, Richard Passwater, Ph.D., coined the new term 
“antioxidant synergism”. In “All about antioxidants” (Avery Publishing, 1998) he stated the 
existence of a synergy when the system as a whole has a better effect than the total of the 
effects which derives from the singular parts that make it up. 
The antioxidant activity of vitamin C and E finds its expression in different matrix; in fact, 
while vitamin C operates in aqueous systems, hence on water soluble molecules, vitamin E is 
mainly present in cellular membranes lipids and it’s active against LDL cholesterol oxidation. 
The great advantage of GSE lies on the possibility of expressing both its own antioxidant 
activity in aqueous matrix, owing to its hydrophilic component at the lowest molecular 
weight, and also in lipidic matrix, thanks to lypophilic component at the highest molecular 
weight [32]. 
 
1.2.4.1 Antioxidant activity, higher than vitamins C and E 
The antioxidant activity of a system is measured in relation to its ability of disrupting free 
radicals, responsible of damages (more or less permanent) to those biological systems in 
which they are formed.  
In vitro analyses on the free radical scavenging ability (RSA) were performed by Bagchi 
and co-workers [33].They have discovered an RSA of 84 and 98% higher than that of vitamin 
E, versus the formation of super oxides anions and hydroxyl radicals respectively.In 
comparison with vitamin C, the grape seeds extract afforded RSA values of 439 and 575% 
greater.Additional in vitro studies, which were reported in the literature [18, 34-36] validate 
the hypothesis of a better GSE antioxidant potency than that of the well-known vitamins C 
and E.It’s worth mentioning that, despite in vitro studies give an indication of the potential 
product’s efficacy, they do not necessarily reflect the actual antioxidant power in biological 
systems. However, studies done on animals by Bacghi D. [33] and on human cellular cultures, 
carried out by Bacghi M. [37], have demonstrated that the GSE antioxidant activity is 
significantly higher than that of vitamins C and E, even in biological systems.With regards to 
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analyses on human cells, the experiment was done on oral cheratinocites, treated with 
tobacco’s extract. In fact, this extract causes oxidative damages and scheduled cell death 
(apoptosis). In this case, the pre-treatment with GSE reduces cellular apoptosis to about 85%, 
while a combination of vitamin C and E, reduces it to 46% only. 
 
1.2.5 Antioxidant effect on vitamin E 
As a consequence of GSE antioxidant activity, in comparison with vitamins C and E, some 
researchers have hypothesized a grape seeds extract function, which may allow vitamins to 
become more bioavailable during their recycling phase. 
Maffei Facino and collaborators [38] found a positive match, investigating the effect of 
procyanidines derived from grape seeds both on phosphatidilcolinic liposomes (homogeneous 
system) and also on red corpuscles (heterogeneous system). In either case, a decrease of 
vitamin E reduction content, due to the oxidative processes, was observed. In fact, 
phosphatidilcolinic liposomes, owing to the presence of hydroxyl radicals, undergo a 
peroxidation stage; on the contrary, in the case of red corpuscles, the oxidative stress was 
induced by the system exposure to UVB rays. 
As an alternative, GSE was given orally to some healthy volunteers. By analyzing their 
blood samples, taken at the beginning, at the end and seven days after the administration 
period, Simonetti and his co-workers [39] could verify a significant increase of vitamin E in 
red corpuscles membranes, along with a reduction in membrane lipididic peroxidation 
correlated, in a linear manner, to the vitamin E concentration in the membrane itself. 
 
1.2.5.1 Synergic effect with vitamins C and E 
Vinson J [40, 41] has optimized a set of in vitro tests, in order to investigate the synergic 
activity among vitamins C, E and the grape seeds extract. The employed in vitro models, 
simulate the initial stage of arteriosclerosis. The procedure provides that the measurement of 
LDL (low-density lipoprotein) and VLDL (very low-density protein) oxidation inhibition by 
antioxidant agents. Vitamin C, vitamin E and grape seeds extract were tested separately, to 
establish the basal effect at a wide concentration range. These effects were added up, in order 
to provide “The Individual Inhibition Amount”, which was subsequently compared to “The 
Actual Mixture Inhibition”. 
The Actual Mixture Inhibition subtracted to the Individual Inhibition Amount, carried to 
100, yields the synergy percentage. This set of in vitro tests, has allowed Dr. Vinson to afford 
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the maximum synergism concentrations among the oxidizing species. Furthermore, he has 
observed a strong synergism between grape seeds extract and vitamin C, as well as between 
GSE and vitamin E. 
  
1.2.5.2 Antioxidant effect on LDL and VLDL 
By now, the antioxidant effect of GSE towards LDL and VLDL has been thoroughly 
elucidated. In fact, these type of data may be obtained from simple investigations on the GSE 
antioxidant activity, carried in vitro and in lypophilic phase [35]. Furthermore, the activity on 
LDL and VLDL is the basis of an assay, optimized by Vinson [40, 41], who explored the 
extract’s synergic activity with vitamins C and E (see paragraph 3.3). 
In vivo studies on hypercholesterolemic were done by Talpur N. A. [23], who administrated 
the grape seeds extract in combination with polycotinate chrome (Cr) (ChromeMate). With 
regards to the control (placebo bid and chromium only), a significant decrease in total 
cholesterol as a consequence of a net reduction of LDL levels (placebo effect -3%, Cr -14%, 
Cr+GSE -20%), was detected. On the contrary, HDL values were not subjected to 
considerable variations. 
 
1.2.6 Toxicity studies on grape seeds extracts (GSE)  
Several toxicological studies on different grape seeds extract sources and on different 
administration modes were carried out. 
 
1.2.6.1 Oral Administration 
Studies performed by Bombardelli and Morazzoni [42] demonstrated an LD50 (median 
lethal dose) value equal to 4 g/Kg of body mass. In addition, it was evinced that a daily dose 
of 60 mg/Kg for a time period of 6 months in mice and 12 months in dogs, did not cause any 
toxic effect on treated animals. YamaKoshi J. and coworkers [43] afforded LD50 values even 
higher than 4 g/kg. They investigated the GSE mutagenic action through a reverse mutation 
test, a chromosome decay test, micronuclei test and found no mutagenic activity relatively to 
the GSE. 
Studies by Bagchi D. and collaborators [44] reported an increment of LD50 value up to 
5g/kg body mass when orally administered in both male and female albino rats, via gastric 
intubation. 
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1.2.6.2 Studies of acute epidermic toxicity 
Bagchi D. and co-workers [44] have epidermically administered a 2 g/kg body mass dose to 
five male white rats and 5 female ones. A 24 hours exposure using semi-occlusive bandages, 
induced exclusively a slight erythema along with a moderate desquamation in all treated 
subjects. Such effects later disappeared within 12 days or even earlier. 
Therefore, in case of a 24 hours administration on unwounded skin, the LD50 value was 
estimated to be higher than 2 g/kg body mass. Moreover, a 2 g/kg dosage resulted as the 
NOEL (no-observed effect-level) value in case of a systemic toxicity. 
 
1.2.6.3 Studies of primary epidermis irritation 
A single 0.5 g dose of GSE was applied on New Zealander white rabbits healthy skin for an 
exposure period of 4 hours, under semi-occlusive bandages. The application sites were 
evaluated according to Draize methodology after 30-60 minutes, then after 24, 48, 72 hours 
from the bandages removal and subsequently once a day until the 12th day, in case of a 
persistent irritation. The primary irritation index was estimated to be 2.7, which counts GSE 
in the class of moderately irritant substances [44]. 
  
1.2.6.4 Primary irritation on albini rabbits eyes 
Bagchi D. and co-workers [44] have given an 85 mg single dose of GSE by injection 
directly in the right eyes inferior conjunctival sac of 6 rabbits. The eyelids were closed for 
approximately 1 s and right after they were released. In accordance with Draize methodology, 
the ocular reactions were examined. The highest value was 16.7, reached at 24hrs from the 
instillation. The encountered irritation is completely reversible within fourteen days. 
 
  
1.2.7 Use as food preservative 
All foods and drinks undergo gradual changes during their preservation. Setting aside the 
degradation caused by microorganisms, the typical causes of rancidity is ascribed to the 
presence of oxygen and products derived from molecules chemical oxidation. The 
selfoxidation process entails different steps and the rancidity development involves a chain 
mechanism, driven by the presence of free radicals. Furthermore, the quality of the lipids, 
deteriorates in conditions of oxidation promoted by light and temperature. For this reasons, 
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most of the time manufactured products have food preservatives added. Preservatives 
commercially in use are benzoates, sorbates and synthetic antioxidants, such as BHT and 
BHA. In the optics of improving the quality and the products maintenance, without resorting 
to synthetic chemical substances, the scientific research is committed to the discovery of 
powerful and safe preservatives of a natural origin. A particular attention has been focused on 
natural extracts, obtained without the introduction of chemical solvents. 
Owing to the ability of the GSE to act as scavenger of peroxy radicals and as a strong 
antioxidant, studies were focused on their effectiveness as "food preservatives". In this way 
food added with GSE should not to be subsequently added with preservative, with the aim of 
maintaining the product’s integrity over a time period (BHA, BHT), as well as to have a 
strong nutritional value, given by the presence of polyphenols and their various biological 
activities. 
Investigations conducted on a commercial product and published over the internet, showed 
that the GSE possess a greater activity than that of BHT and BHA. Studies were performed by 
analysing the quantity of hexanale developed from the food in a certain period of time, 
comparing the obtained value with the one afforded from rancid food. 
 
1.3 Interaction polyphenols-thrombin 
 
1.3.1 Thrombin 
Thrombin is a plasma constituent that has several activities: promoters the conversion of 
fibrinogen into fibrin and of factox XIII into factor XIIIa [45], by stabilizing the fibrin 
polymers; it promotes the piastrinic aggregation, by activating the receptors of activated 
protease (PARs) [46], and also of the cancer growth, the artheriosclerosis and inflammatory 
processes, the mioblast survival, the neutrophilic survival, the apotosis/survival of the neurons 
in glyal cells; moreover the thrombin is able to promote the chemiotaxy of monocites through 
a non proteolitic mechanism. 
 
1.3.2 Molecular structure 
Thrombin is a serin protease glicosilated from the family of tripsins. Like all the other 
enzymes of the tripsin family, it has a catalytic triads ( Asp102, His57, Ser195) and the two 
amminoacid Asp189 and Glu192 ( charged residues with an important role in the recognize 
and binding of the substrates and inhibitors), fundamentally inside of the active site.  
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The human thrombin can exist in three forms: α, β e γ, even if in vivo this last structure has 
never been demonstrated. By means of proteolitici fragmentation  or tryptic, the β and γ forms 
are generated and they mantain the same primari structure and the same active site of the α 
form, with the exception of more chains not covalently binded. 
The α-thrombin is a molecole of 36.6 kDa with an isoelectric point of 7.0-7.6 and is formed 
by two chains: the A chain (4,6 kDa) of about 36 residues and the B chain (32 kDa) of 259 
residues, containing the catalytic site, and linked togheter by a disulphure bridge [47]. This 
molecule can be described like an ellipsoid  with 45x45x50 Å dimensions. It’s a and B chains 
are organized in separate domains but they form an unic continuos body with a non continuos 
surface. Like the other serine protease tripsin-like, it is formed by two similar domains, barrel 
like, constituted by six linked β−sheets and from various other random-coil structures and 
α−helix on the surface. The catalytical residues   are localized between the junctions of this 
two barrel structures, with the discontinuity of the active site on the surface. The characteristic 
of this discontinuity and the presence of two extroflections  able to block the active site ( 
produced by aminoacid Trp60d and Glu192) play an important role in the selection of 
substrates and macromolecular inhibitors [48, 49]. 
It is possibile to observe wide zones of charged residues . manly positive, in the 
surroundings of the α−helix C-terminal of the B chain and on the surface of the segment 67-
80. Such residues are involved int the electrostatic interactions, fundamental for the 
stabilization of the A chain, for the coesion of the two chains and for the composition of the 
two binding sites[50]. 
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Fig. 4: Rapresentation of the molecular structure of the α−human thrombin 
Functional studies have evidenced that the thrombin is an allosteric enzyme that exists in 
two different conformations in rapid equilibrium: the slow form and the fast form [51]. The 
slow form plays and important anti-coagulant role, by interacting with the thrombomodulin, 
activate the protein C generating a strong inhibitor of the coagulation that inhibits the factor 
Va and VIIIa; instead the fast form gives to the thrombin the characteristically role of 
procoagulant agent. The transition slow-fast is inducend by the binding with Na+  , that binds 
to the molecule in a site near to Asp189, at more than 15 Å from the catalytic triads, inside of 
a cilindrical cavity formed by three antiparallel β-strands of the chain B. This shows an 
ottaedric coordination that involves the amminoacid Tyr184, Arg221, Lys224 and three water 
molecules[52]. In physiological conditions of concentration of Na+, pH and temperature, the 
two forms are present in similar concentrations and they help in maintaining the equilibrium 
between the pro and anti coagulant activities. 
 
1.3.3 Reaction mechanism. 
In figure 16 is evidenced the mechanism of general reaction of the serine protease [53]. In 
bold are evidenced the aminoacid of the catalytical triads. Ser195 is activated by nucleophile 
attack from His57 at the carbonylic of the scissile binding. The acilation (a) procedes through 
 14 
the formation of an tethraedric intermediate, stabilized by the interactions between the oxygen 
atom negatively charged of the substrate and the aminoacid 193-195 of the protease chain. 
The deacilation proceeds through addition of water (b); R and R1 indicate the fragments that 
are found upwards and downwards respectively. 
 
 
 
Fig. 5: Reaction mechanism of the serine protease 
 
1.3.4 The coagulatory process 
After a vascular damage, the thrombin plays an important role in the process of coagulatory 
cascade. This process has in its principal phase the activation of the factor X in Xa factor and 
my develop through two different ways: the internal and external way. The internal way needs 
that  the activation of the X factor begins when, after a damage in blood vessel, the blood 
came in contact with different surfaces from the vascular endothelium (collagen, basal 
membranes) provoking the activation of precallicrein in callicrein and factor XII in factor 
XIIa. This last provokes the conversion of factor XI in Factor XIa, that, in association with 
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calium ion, piastrin phospholipids and factor VII (antiemofilic) determines the activation of 
factor X. The external way instead, is more rapid and begins as a consequence  of a vascular 
or tissue damage and a release of a membrane glycoprotein ( tissutal factor) that in association 
with the factor XII, present in blood,  cause the activation of the factor X [54]. The factor Xa 
(a serin-protease) forms a complex, known as prothrombinase, with the factor Va in presence 
of calcium ions and phospholipids[55]. Is this complex that determine the conversion of 
prothrombine  ( the inactive zimogen sintetized in liver and present in plasm) in thrombin. 
This process needs the hydrolysis of two internal peptidic binds (Arg271-Thr and Arg320-
Ile) that reduces the molecular weight of the precursor from 71,6 to 36,6 kDa, while the 
second determine the formation of the active thrombin. 
The calcium ions necessary for the conversion prothrombin-thrombin and for the increase of 
affinity of prothrombin for the superficial phospholipids of endhotelial cells, binds to some 
residues of γ-carbossiglutammic acid present in the C-terminal of protrombina and to 
carboxilates by a carboxilase-vitamin K dependent. 
Once formed, thrombin catalyze the process of formation of fibrin coagulum from 
fibrinogen. In this process four peptidic Arg-Gly bonds are broken  in the N-terminal region 
of the fibrinogen with conseguent release of fibrin-peptides and a monomer of fibrine [56] so 
it could not undergo self-activation. The monomers polymerize linearly in order to give origin 
to an insoluble coagulum that is made even more stable by further covalent bonds ( covalent 
cross-linking) made by the intervention of the factor  XIIIa [57] and by incorporation of 
piastrine,  blood cells and thrombin [58]. 
 
1.3.5 Thrombin inhibitors 
The most important physiological thrombin inhibitor is without doubts the antithrombin[59, 
60], this molecule  ( or also called antithrombin III) is a polypeptide glicosilated at single 
chain, with a mass of almost 68 kDa. This protein belongs to the serpins family, inhibitors of 
protease to whom belongs the  α-antitripsin.  
The antithrombin is synthetized in the liver and circulates in a  plasmatic concentration of 
approximate of 2,6 µM. This inhibits the factors of the activated coagulation of the internal 
way and common way, comprehending | the thrombin, the Xa, IXa, XIa and XIIa factors and 
the callicrein; it has however a low activity or none in comparisons with the VIIa factor. The 
antithrombin is a "suicidal inhibitor" for this protease; the inhibition in fact happens when the 
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protease attaches an Arg-Ser specific peptidic bond  in the reactive site of the antithrombin 
and is trapped like a stable complex 1:1. 
Some inhibitors of the thrombin exploit the potentialities of the antithrombin, so they 
behave their inhibitory activity by binding themselves to this molecule. Among this group of 
inhibitors, defined antithrombin-dependent, the more remarkable and effective is heparin, or 
the heparins with low molecular weight (LMWH). However, the complex heparin-
antithrombin are weak inhibitors for the binded thrombin over surfaces, maybe due to the  
difficulty of formation of the ternary complex [61] , and this event represents a pharmakinetic 
limit [62]. 
The more  powerful “direct” inhibitors of the thrombin, are thse that do not  require the 
antithrombin as cofactor, for example like the irudin, the melagratan and the [62] argatroban. 
The irudin is a powerful and specific inhibitor of the thrombin initially found  in the salivary 
glandses of the medicinal leech. This peptide of 65 or 66 amino acids, possesses a dominion 
N-terminal with globular form that interacts with the active site of the thrombin, while the 
dominion C-terminal binds  the exosite 1. The irudin binds the thrombin with high affinity 
forming a reversible complex with 1:1 stoichiometry 
Some derived of this molecule il the lepirudin, the desirudin and the bivalirudin. The 
melagratan is a dipeptide that mimic the portion of fibrinpeptide A that interacts with the 
active site of thrombin. While the melagratan is badly adsorbed by gastrointestinal tract, the 
ximelagratan, one of its derivatives, is well absorbed and doesn’t show  any interaction with 
food or other medicinals.  The argatroban is a small synthetic molecule (MW=526,66) that 
acts like competitive inhibitor for thrombin. It’s a derivative of arginin and interacts only with 
the active site of thrombin. The argatroban is metabolized in liver with a process that 
generates at least three active intermediates. 
 
 
1.4 Interaction Polyphenols-Plasmin/Plasminogen 
 
1.4.1 The system Plasmin/Plasminogen 
The system Plasmin/plasminogen (PPS) [63] is a proteolytic system that is involved in many 
physiological and pathological processes. It includes a series of components, characterized by 
a different structure and biological activity. 
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The Plasmin is a serine protease [64] with an high specificity and is capable to activate od 
degradate the coagulation components of the methabolism of kinine and the omplementary 
system. Even if the Plasmin can be inhibited by a various number of plasmatic inhibitors in 
vitro, the regulation of Plasmin in vivo is belived to be made through the interaction  with the 
l’α2-antiplasmine, and in a diminished manner, with the α2-macroglobulin [65]. 
 
 
Fig. 6 Rappresentation of the primary structure of plasmin. 
 
 
The Plasminogen is converted into Plasmin, an active serine protease, by hydrolysis of the 
peptide binding Arg560-val561 producing an heavy NH2-terminal (A) and a light chain 
COOH-terminal  (B) binded by two disulphure bonds. This conversion is catalyzed by a 
variety of physiological and pathological activators, including the plasminogen urinary 
activator uPA, the tissutal plasminogen activator tPA, the streptokinase, the kallicrein and the 
factors IXa and XIIIa [66]. The light chain COOH-terminal (MW=26kDa) contains the 
catalytic triads  and the active site versus the streptokinase. The heavy chain NH2 –terminal is 
included in an 12-63 kDa range, depending from the Plasminogen kind from wich has origin. 
In absence of inhibitors, the Plasmin cuts from the Plasminogen itself the N-terminal Glu1-
Lys76plasmin in order to give the form Lys77-plasmin, that has an higher affinity for the 
fibrin of the Glu1-plasmin form. The heavy chain Lys-Plasminogen contains 5 homologue 
internal regions binded by disulphure bridges known as kringle. The regions from kringle1 to 
kringle4 contain binding sites for the ω-aminocarbossilic acid and for the fibrine. Moreover 
exists also  the form Val442-plasmin produced by hydrolysis of elastase[67]. 
 
1.4.1.1 Role of the system PA-Plasmin in angiogenesis   
The plasmin is a wide spectrum protease belonging to the family of tripsins; it is belived 
that it can easily hydrolyze both directly and indirectly, through the activation of particular 
pro-MMP, various extra cellular proteins, the most important of it is fibrin. The uPA and the 
tPA, the main activators of Plasminogen, are the products of two different that are regulated 
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independently by different factors, like hormones and cytokines.   Like for Plasmin, uPA and 
tPA are serin protease belonging to the family of tripsin, but differently from plasmin, they 
present a less specificity for the substrate, the Plasminogen. The uPA ( or more prcisly, its 
inactive precusros pro-uPA) is secreted like a soluble protein and bings with high agginity to 
a specific receptor binded on the cellular surface with an anchor GPI (receptor uPA, or 
uPAR), present in many cells, like epithelial cells. The Plasminogen and the plasmin bind 
togheter with plasmatic membranes, and the co-localization of the uPA and of Plasminogen 
on the cellular surface increments the grade of activation of Plasminogen and the consequent 
proteolysis plasmin-dependnet. The existence of more specifical physiological inhibitors of 
plasmin (α2-antiplasmin) and of PA (PAI1 and PAi-2) gives more points of regulations to this 
process. The specificity, the activity and the localization of the inhibitors of the seine protease 
can be regulated by ECM and other glycoproteins[66, 68]. For what regards the stydies of 
localization, essentially uPA, uPAR and PAI-1 are not expressed in the quiescent 
endothelium. In different terms, the tPA  was found int the quiescent endothelium of a small 
amount of arterioles, venules and vasa vasorum of normal human tissues. In contrast, uPA, 
uPAR and PAI-1 are expressed durin the angiogenic process in vivo with different modalities. 
uPA and uPAR seem to be expressed in the endothelial cells, depending on the situation, 
while PAI-1 is expressed both in endothelial cells and non-endothelial cells. (stromal and 
endothelial), where is believed to act with an important role in the maintaining of integrity of 
the matrix [69, 70].  
Very few is known about the expression of tPA durino angiogenesis. These observation in 
vivo are widely supported by results obtained in vitro. That grown endothelial cells  were able 
to produce uPA, uPAR,tPA and PAI-1 was already known, and their regulation from bFGF 
and VEGF wan widely studied [69]. It must be evidenced that endothelial cells with human 
origin respond more slowly related with similar cells from bovine towards the induction of 
PA from bFGF and VEGF. The reason of this reduced response can be correlated to the 
chronical stimulation of this cells from components of the endothelial growth (FGF and 
probably VEGF) used in cells culture. The response to VEGF seems to be dependent from the 
vascular bed from where they are isolated. So VEGF induces uPA and tpA in endothelial cells 
derived from capillaries but not in cells derived from aorta [71, 72]. 
This distinction may have  several implications in the regulation of angiogenesis, that 
normally is believed to be dependent from already existing vessels in the microcirculatory 
system. It was reported that the ipoxy, one of the most important stimuli in angiogenesis, can 
increment uPAR [73] and PAI-1 [74] in endhotelial cells. The angiogenesis determines the 
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formation of new blood vessels in the circulatory system. A comparable process called 
lymphoangiogenesis, is responsible of the formation of new vessels in lymphatic system. The  
lymphoangiogenesis is traditionally eclipsed by the major attention dedicated to angiogenesis. 
This is partially due to the lack in the identification of lymphoangiogenesis factors as markers 
capable to distinguish  the blood from the lymphatic vascular endothelial. This situation is 
rapidly evolving following the discover  of the first lympgoangiogenic factors ( VEGF-C and 
D) and of some other specific markers of lymphatic endothelium [75]. In adult tissues, new 
lymphatic capillaries are developed as extension of previously existing and at the same time 
new capillaries are created by pre-existing microvascular system during angiogenesis. Even if 
we know little of the mechanism regarding the lymphoangiogenesis, it was demonstrated that 
VEGF, VEGF-C e bFGF are able to stimulate  uPA, uPAR, tPA e PAI-1 in endothelial cells 
of the biggest lymphatic vessels [76-79]. The relevance for the lymphoangiogenesis in vivo of 
this in vitro data has to be clarified. The production of mice without the system PA-plasmin 
have given an opportunity in order to elucidate the role of single componensts of this 
particular system  durin angiogeneisi in vivo. Previous studies, both in vivo and in vitro, have 
evidenced the crucial role of the PA-plasmin during angiogenesis. Unexpectedly it was found 
that the embional and post-born  development it was not influenced by this system, at least in 
the casof the phenotype associated with angiogenesis [69]. One study conducted on the 
healing of wounds of mice deprived of plasminogen have definitely clarified the role of the 
system PA-plasmin during the migration of cheratinocites in vivo [80]. In every case, even if 
the migration of cheratinocites was rapidly altered, the wasn’t no qualitative difference in the 
granulation tissue (infiltration of inflammatory cells , fibroblast migration and neo-
vascularization) between wild-type mice  and without plasminogen; this has suggested  that in 
this case the angiogenesis is not PA-plasmin dependent. Moreover the expression of six 
MMP,  like for example MMP-1,-3 and -9 MMP-2, was not influenced in mice without 
plasminogen. This results have indicated that even if the cheratinocites migration is plasmin 
dependent, the execution if the genetic program that controls the migration is plasmin 
independent. Even if the angiogenesis associated to growth and to the cure of wounds, seems 
not to be influenced in mice  without uPA, uPAR, tPA, PAI-1 and plasminogen, sevcral 
studies in vivo have evidenced the necessity of this system during angiogenesis associated to 
other process. For example, the cancer angiogenesis ( vascular density) is inhibited in mice 
without thymus using human carcinogenic cellular lines PC-3, transfused with human PAI-1 
[81]. Even if this study shows a role of PA in the tumarl angiogenesis, it hasn’t given andy 
mecchanicistic informations. More detailed informations were given in a heart attack of the 
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myocardium, where the new myocardium vascularization was seriously altered in mice 
destitute of uPA [82]. 
Since this kind of phenotype can’t be saved by adding of exogenous VEGF, and since 
endothelial cells and the smooth musculature express uPA during the revascularization, it was 
demonstrated that a defect in the angiogenesis is due to the altered invasion of endothelial 
cells.  In particular, if assayed in the corena of rabbits or in chicken CAM, the uPA itself has 
demonstrated a pro-angiogenic effect [83-85]. In CAM, this event can be attributed to the 
relay of bFGF engoenous [85]. 
 
1.4.1.2 The interaction uPA-uPAR is requested for angiogenesis. 
The importance of the interaction between uPA and uPAR dring angiogenesis is shown in 
different systems in vivo. The angiogenesis induced by bFGF in atrigel by subcutaneous 
injection was inhibited by a fusion protein that consist in a ammino termina fragment of the 
specific uPA for the receptor and the Fc portion of the human IgG, that acts as high affinity 
antagonist  for the uPAR [86] At the same way , cancer models  on synergic rats  and 
XENOGRAFT, the amino-terminal fragment diffused by adenoviruses  was able o inhibit  the 
cancer angiogenesis [87].  In an analogous model of rats immunocompetent of cancer cells 
transfused with human mutant uPA, that allows the conservation of the binding with the 
receptor but not the proteolitic activity, the microvasal density was diminished [88]. The 
cancer angiogenesis in different murin models was inhibited by an octa-peptide deriving 
froma  region of the uPA not binding for the receptor [89, 90]. This studies  have defined a 
new epitope in uPA involved in the interaction uPA-uPAR. 
 
1.4.1.3 PAI-1 is necessary for the angiogenesis. 
Studies of localization have shown that  PAI-1 is highly expressed in endothelial cells in a 
series of cancer types [69]. Studies on mice that do not express PAI-1 have revealed an 
absolute necessity  of PAI-1 in the induced cancer angiogenesis. 
In a model, cancer and stromal cells are separated by interposition of a collagen gel of type 
1, that allows the evaluation of added esogen cancer cells  and invasive guest stromal cells 
[91, 92]. The absence of PAI-1 ( but not of uPA, uPAR or tPA) in the guest may alter 
significatively  the invasion of cancer cells  and the neo-vascularization guest-derived. The 
inversion of this phenotype  is realized from mice that do not express PAI-1 to which was 
distributed human PAI-1 as adenovirus. In wild-type mice, the expression of PAI-1 in stroma 
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can be localized in endothelial cells and not endothelial. Suprisingly, even if uPA is localized 
in blood vessels formed in wild-type mice, uPA was substituted by tPA in mice that do not 
express uPA, demonstrating  the capacity of cmpensation between the PA’s. The request of 
PAI-1 ( but not of uPA) during the cancer angiogenesis was demonstrated in a model of 
fibrosarcoma in the genetic inactivation of mice [93]. The corneal angiogenesis induced by 
bFGF is simply blocked by PAI-1 but not in mice where is not expressed uPA- Two possible 
mechanisms can explain the reason why pAI-1 is essential during angiogenesis. In the first by 
protection of ECM against excessive degradation, PAI-1 provides to the maintaining of the 
structure of the matrix requested for the endothelial cells migration and for the formation of 
tubules [94]. In the second mechanism a complex series of interactions between PAI-1, uPAR 
and the vitronectine was described [95-97]. Alterations of the expression and the activity of 
PAI-1 can alter the adhesive, migration  and growth  properties of endothelial cells, that 
subsequently may be able to regulate angiogenesis. In order to redirect directly this issue, 
adenovirus was used to distribute the mutant forms of PAI-1 to mice that do not express PAI-
1. The mutants of PAI-1 either bind normally the vitronectine but do not inhibit uPA or tPA, 
or they inhibit normally the PAs  but  they do not bind relevantly to vitronectine. The 
angiogenesis is restored by mutants of PAI-1 that maintain the inhibitory effects for PA but 
not for mutants that bind to vitronectine  but do not inhibit the PA, demonstrating that the 
necessity for PAI.1 in this model is due to the inhibition  of excessive proteolysis rather the 
inhibition of cellular adhesions to vitronectin. In a different study was reposted that the 
addition of exogenous PAI-1 have induced the angiogenesis induced by bFGF in Cam [98]. 
By he use of diversion-mutants of PAI-1, this activity can be attributed to both anti-proteasic 
activity of the PAI-1 ant to its capacity of binding to vitronectine. 
 
1.4.1.4  Role of the tPA in the angiogenesis 
Few informations are available on the role of tPA in the angiogenesis. In vivo the antigen 
for tPA is localized in the microvascular endothelium  [99], hat as revealed in morphological 
studies, is the region of the vascular bed where new blood vessels are formed during 
angiogenesis. The presence of tPA in the angiogenic endothelium has to be described yet. In 
vitro, tPA is implicated in the formation of capillaries tubules on matrix of collagen  of type 1 
and Matrigel [100-104]. The necessity of tPA  in the migration of endothelial cells  in vitro 
was studied with different results [105, 106]. Surprisingly, the combination of bFGF abd 
VEGF have induced the activation of tPA mRNA and of the enzyme in  synergic way in 
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coltures  of endothelial cells [72]. Analysis of immunofluorescence have revealed that cells 
associated to tPA was co-localized with the von Willebrand factor, a marker of Weibel-
Oalade bodies, that are mantaining grains specific for epithelial cells. A combination of bFGF 
and VEGF have raised the number of positive tPA cells like for the number of tPA grains 
positive for the cell.    
The angiostatin, an endogenous inhibitor for the angiogenesis, have shown to be able to 
inhibit  the activation of plasminogen catalyzed by tPA in endohelial cells [107]. At the 
moment is possible only to suggest possible functions of tPA in the Weibel-Palade bodies in 
the contest of angiogenesis. An important role can be the protection  of blood vessels  formed 
after thrombotic occlusion. The stagnant blood in the formation of “close roads” of new blood 
vessels can be easily subject of coagulation, due to potential exposition of blood to ECM ( 
and in particular to collagen), and to the blood coagulation activatd can be removed less 
easily. In order to overcome to this problem , the thrombin generated locally  can be resulting 
in an acute release  of tPA by the Weibel-Pallade bodies [108, 109], that can result in a 
removal of fibrin deposits. It is interesting to notice that the secretion of MMP-1 and MMP2, 
but not  of TIMP-2, can be realized through a post-traslational mechanism in endothelial cells 
[110].  The MMP are  regulated at different levels: in endothelial cells, the stimulation  of 
MMP can happened during secretion., giving a mechanism for the rapid mobilization of the 
initial phase of angiogenesis. It has to be cleared if this enzymes, like tPA, are localized in the 
Weibel-Palade bodies. The intracellular accumulation of MMP-9 in the secretive vescicles as 
response to ester of forbolo was reported [111]. 
 
 
Fig. 7: The system plasmin/plasminogen in colon cancer 
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In this work we have tried to study and characterize from a kinetic and thermodynamic point 
of view the interaction of plasminogen and plasmin with two flavonoids ( quercitin and rutin) 
by utilization of SPR Biosensor, spectrophotometric  and fluorimetric assays coupled with 
procedures of molecular modeling. 
 
 
Fig. 8 : Molecular structure of quercitin and rutin 
 
 
Quercitin is one of the most common and present flavonoid, and can be assimilated through 
fruits and vegetables with an approximate consumption of 16 mg/die [112]. It was shown that 
quercitin has a mutagenic and antimutagenic function, and is considered as inhibitor of 
carcinogeni effects  and as potential chemopreentive agent versus cancer [113-115]. Further 
studies  were pointed to the determination of the effective dosage  and the relative toxicity, in 
order to  evaluate the possible utilization in the prevention in the formation of malignant 
human pathologies. Rutin is a glycosilated  form of quercitin (quercitin-3-rutinoside) and is 
hydrolizated in liver [116].  
Quercitin was found to be abundant in onions (284-486 mg/kg), broccoli ( 30 mg/kg), 
lettuce (15 mg/kg), tomatoes ( 8 mg/kg). In fruits quercitin was found to be present at a 
medium concentration of 15 mg/kg. In a similar study it was determined the concentration of 
quercitin in tea infusions, grape juices and wine.  
This compounds  are essentially known as natural antioxidants [117], and they exhibit a 
protective action towards the oxidation of membrane phospholipids [118], nucleic acids [119] 
and proteins [120]. 
It was also recently reported that  this kind of molecules can act as specific binding/effectors 
of a series  of macromolecules involved in relevant physiological processes [121-123] and in 
particular, they can modulate the enzymatic activity of elastase [124], a serine protease 
belonging, like plasmin, to the family of tripsin-like family. 
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1.5 Interactiuon polyphenols-DHFR 
1.5.1 The dihydrofolate reductase: function and structure. 
The dihydrofolate reductase ( DHFR, EC 1.5.1.3.) is an ubiquitary enyme NADPH-
dependent that catalyze the reduction of 7,8-dihydrofolate (H2F)  to 5,6,7,8,-tethrahydrofolate 
(H4F). At acidic pH it catalyze the reduction of folate to tetrahydrofolate involving two 
equivalents of NADPH. 
 
Fig. 9: Reactions catalyzed by DHFR 
This enzyme is fundamental in the manatining the quantity of  intracellular H4F and its 
derivatives, involve in the transfer of monocarbonic units in several methabolic processes like 
the biosynthesis of purines, of timidilate and several aminoacids: 
 
Fig. 10: Role of the DHFR in the biosynthesis of nucleotides 
In figure 36 is reported a critical reaction associated with the activity of DHFR: the 
conversion of 2-deossiuridilate to deossitimilidate, used for the synthesis of DNA. The 
intervention of DHRF in metabolic  connected with the synthesis of DNA gave to the 
scientific community great interest towards this enzyme since the half of the fifties, when was 
discovered the ancticancer activity from one of the most powerfull inhibitor of the DHFR, the 
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metotrexate. It’s an analogous of folate that present a a costant of equilibrium of association 
for the enzyme of an order of 1010 M-1. 
 
 
Fig. 11: Structure of Folate and Metotrexate 
 
1.5.1.1 Mechanism of reaction: 
Recent studies on DHFR [125] have evidenced an intrinsic structural flexibility of the 
protein that allows to overcome to the rigidity request imposed by the formation of a reactive 
complex, with the capacity of discriminating between substrate and produt of reaction through 
the fine modulation ligand-dependent. 
The reaction catalyzed by DHFR from E. Coli involves the formation of a ternary complex 
DHFR:NADPH:H2F by which happens the transfer f the hydrogen pro_R from the cofactor 
NADPH at the C6 carbon of the pteridinic ring of the dihydrofolate with consequent 
protonation of the nytrogen N5 of the substrate. The reaction is strongly pH dependent and is 
characterized by a pKa of 6.5 and a transfer rate  velocity for hydride of 950 s-1. [126] 
The correct positioning f the substrate relative to NADPH, inside of the binding site, 
constitute a critical factor in determining the reaction velocity, as the right orientation of the 
side chain of Asp27 that represent the chemically significative residue for the formation of 
transition state. 
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The proposed reaction mechanism request infact to it has to be established a network of 
hydrogen bonds inside of the active site of the enzyme, involving the Trp22, Thr113 and a 
molecule of water [127]. 
Muthagenesis specific-site studies [128-131] have demonstred that sustituions of Trp22 and 
Thr113 are able to determine a diminution on the affinity for the substrate without affecting 
the transfer-rate velocity of hydride  from NADPH to DHFR. From this results is possible to 
attribute the most significant role, in the mechanism  of catalysis of DHFR, to Asp27, while 
the already cited residue responsible  of the formation of hydrogen bonds inside the pteridinic 
ring of DHFR, and some hydrophobic residues (Leu28, Phe31,Ile50 and Leu54) that are 
found to be in contact with the substrate, seems to have a marginal role in the transfer process 
of hydride, but fundamentally  in the correct positioning of the DHRF respect to NADPH and 
asp27. Based on crystallographic studies, NMR spectroscopy and Raman [130] is possible to 
describe the reaction mechanism based on a cheto-enolyic tautomery induced by the presence  
of a carboxylic group of Asp27. After the binding of the substrate, the concomitant expulsion 
of molecules of water from he catalytic site brings to a lowering of the dielectric constant of 
the surrounding of the carboxylate residue of Asp27 and a consequent rising of the pKa. The 
carboxylic oxygen after this shift of pKa, in proximity of the N3 hydrogen of the pteridinic 
ring, promotes the formation of the enolic tautomer inducing an electronic shift towards N3 
and allowing the protonic transfer from a molecule of water to O4. This enolic intermediate 
results favourable in the hydride transfer from NADPH to c6 of dihydrofolate and at the same 
time allows to stabilize the negative charge of the COO- group of the Asp27 inside of the 
hydrophobic pocket. Subsequently to the transfer of hydride a proton is released from the 
enolic O4 to the pteridinic N5 leading to the formation of H4F and to the restoration of the 
negative charge on the carboxyle of Asp27. An important process based on the catalytic 
mechanism results to be the variation of the dielectric constant  inside of the active site that 
derives from the expulsion of water molecules after the binding of the substrate. Substitution 
of hydrophobic residues, involved in the catalytic site, with more polar side chains that are 
able to determine an higher accessibility to solvent, have shown a negative effect on the 
affinity for the substrate and on the kinetic transfer constant of hydride [132]. Finally it’s 
possible  to indicate that there is a concerted kinetic mechanism that request the coupling of 
precise steric and chemical-physic factors; the correct aligning of the substrate respect to the 
cofactor and the Asp27, assisted by the presence of hydrophobic surfaces that are able to 
block the paraminobenzoic group, inside of the active site, united with the lower dielectric 
constant in the catalysis region, are able to realize the electronic rearrangement of the 
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pteridinic ring of the dihydrofolate to be found in the optimal configuration for the hydride 
transfer. 
 
1.5.1.2 Molecular structure of DHFR. 
The DHFR is a monomeric protein of 17Kda constituted of 159 aminoacids, and its 
secondary structure presents a big central β-sheet formed by eight β segment ( from βA to 
βH), four α-helix and loop structures that connect the different elements of he secondary 
structure and modulate the conformational changes of the enzyme. In spite of the little 
dimensions of the protein, two domains can be found that delimitate the hydrophobic pocket  
involved for the binding site of DHFR: a big subdomain that binds the adenosinic portion of 
NADPH (adenosine-subdomain) and a subdomain rich of loop structures (loop-subdomain) 
[126] dominated by three regions highly flexible: the Met-20 loop, the loop that connects the 
segments βF and βG and the loop between the segments βG and βH. 
The space between the two sudomains generates the inlet of the active site where is able to 
position the cofactor (NADPH) and the substrate (H2F) with an angle of 45° in order to favour 
the transfer of hydride from C4 of NADPH to C6 of H2F. The accessibility of the active site 
towards ligands is regulated by the conformation of the flexible loop Met-20 that exerts an 
action of control of the opening/closure of the binding site towards NADPH. The presence of 
a rich subdomain rich in loop structures makes the DHFR a protein highly flexible. The 
possible conformations assumed by the enzyme after the concerted movement  rotations of 
the two subdomains and the obscillation of the loop Met20 rapresent an efficient mechanism  
of regulation of the catalytic activity of the DHFR. 
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Fig. 12: Structure of DHFR: ternary complex DHFR:H2F(yellow):NADPH(green) 
From crystallographic data [133], all the sudomains of DHRF are stabilized by the presence 
of hydrophobic clusters: particularly in the major domain we can find a large cluster if 
hydrophobic  formed by six leucyne  (Leu4, 8, 104, 110, 112, 156), two tyrosines (Tyr100, 
128) two phenylanine (Phe103 and Phe125), two valins (Val93 and Val99), two alanins (ala6 
and Ala107) and Trp133 and Ile2. This group of hydrophobic chains stabilize the interface 
between the central β-sheet and the helix αF, while on the other side of the β-sheet ( in front 
of the helix αB) there is a cluster of minor dimension composed by the side chains of Ile5, 
Trp30, Met92, Tyr111, Phe137, Tyr151, Phe153 and Ile155. Since this two hydrophobic 
clusters are linked with the central β-sheet is possible that they are able to act as a single rigid 
unit [133]. Also in the other subdomain more flexible is present a group of hydrophobic 
residue (Met42, Trp47, Ile61, Val72 and Trp74) that are able to maintain a  constant spatial 
position during the subdomain movements involved in the catalysis mechanism. 
The catalytic turnover of the DHRF involves the conformational changes of the enzyme to 
which are associated the skid movements of the interface and the αB and αC helix ( that are 
able to determine the enlargement of the binding site of the substrate), and the movement of 
oscillation of the loop Met20, that regulate the entrance and the exit  of the cofactor from the 
catalysis environment. In particular in  the Michaelis complex DHFR:NADPH:H2F both the 
active site and the loop Met20 are found to be in a close conformation that determines an high 
affinity  for the substrate and for the reduced cofactor. Once there is an hydride transfer, the 
socket of the active site opens and the loop Met20 has a conformation that blocks the 
positioning of the NADP+ and  induces the leaving of the catalytic site with consequent 
formation of the complex DHFR:H4F  that presents a low affinity for both ligands and so, for 
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the saturating concentration of NADPH, provokes the dissociation of the H4F in order to form 
the binary complex DHFR:NADPH where the loop Met20 has the close conformation ready 
to start a new catalytic cycle. Recent studies have evidenced a wide variety of biological 
activities  of catechin, mainly of EGCG, the most abundant flavonoid component in green tea  
and various beneficial effects among them the antioxidant activity, antibiotic and antiviral 
[134-136]. Some authors consider EGCG as a potential anticarcinogenic agent [137]. Green 
tea extracts have sown in vitro to provoke the apoptosis of several cancer cells, like prostate, 
lymphoma, colon and lungs [137-140]. 
It has been reported also that EGCG is able to inhibit the cancer invasion and the 
angiogenesis, two process necessary for the cancer growth and metastasis [137], even 
throough mechanism not already cleared. On the basis of the observation that classi antifolate 
compounds (MTX) have chemical structures similar to some polyphenols [141], it was 
hypotized that catechins ( and in particular EGCG) are able to inhibit the activity of DHFR. 
 
1.6 Interaction polyphenols- proteasome 20S. 
 
1.6.1 The complex of the multicatalitic protease and the degradation 
of oxidized proteins. 
 
1.6.1.1 The control of the protease through proteic autocompartimentation . 
The proteic degradation  is fundamental in the regulation of several physiological process 
like the maintaining of homeostasis during continuous reconstruction of cellular structures, 
both during the development and as response of externals stimulations, the removal of 
misfolded proteins after mutations, oxidative stress or heat, the elimination of regulatory 
proteins in defined moments ( cycline, transcriptional factors, components of signal traduction 
paths and the degradation of external antigens  and the consequent production of 
immunocompetent peptides. Since the degradation represents a possible risk, it has to be 
checked through space and time in order to prevent the removal of proteins not destined to 
proteolysis. A potential control strategy  of the proteic degradation is represented by  
compartmentalization, defined as the ability to define  the proteolitic action to sites that result 
accessible only to protein with degradation signals. The prokaryotic cells that do no posses 
membrane compartments  or vescicular transport systems have developed a different 
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compartmentalization, defined as autocompartimentalization, defined as the formation of a 
commune architecture where different proteolitic subunits are able to form cylindrical 
structures where the catalytic sites are confined in the internal cavities ( several nanometres of 
diameter) [142]. 
The access to the internal compartments is generally limited to unfolded polypeptides, able 
to pass through narrows pores or entering channels.   The target proteins must be able to to 
interact with a system able to bind to them and to be presented to the catalytic site in an 
unfolded way. 
Since preotein unfolding and folding are related mechanism, it is supposed that the 
unfolding complexes are ATPasic  ones, partially similar to chaperionine and defined as 
inverted chaperonine or unfoldase. Sinche their action request the hydrolysis of ATP, the 
protein degradation is a energy-demanding process. The proteasic autocompartimentalization 
is common for all life domains: archobacetria, eubacteria ad eukaryotes. This is a testimony of 
the importance of one of the evolution principles. Differing from organelles, the 
autocompartimentalization offers more flexibility: by having appropriate localization signals, 
suche proteasic complexes can reach different cellular districts where is necessary their 
action. 
 
1.6.1.2 The proteolitic system ubiquitin-proteasome: 
The turnover in normal and altered proteins is realizaed principally by a proteolitic system 
ATP-ubiquitin-dependent, present in nucleus and cytoplasm of eukaryotic cells but also in 
eubacteria and in archeobacteria [142-144].  The proteic substrates destined to degradation are 
marked through covalent binding with multiple molecules of a small protein callled ubiquitin. 
This protein is made by 76 aminoacids with a molecular weight of 8,5 kDa, and it’s higly 
conserved through evolution. The poliubiquitization happens through the sequential action of 
three enzymes: an ATP-dependent enzyme ubiquitin dependent (E1), an ubiquitin cniugating 
enzyme (E2) and and ubiquitin ligase (E3). 
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Fig. 13: Schematic representation of the polyubiiquitinizzation of a proteic substrate and 
further recognize and degradation by a part of the mulicatalytic protease complex 
 
 
 
The three enzymes are able to act simultaneously by realizing a covalent attack to the C-
terminal of ubiquitin to the aminic group of a lysine residue of the target protein. Other 
ubiquitin molecules are able to link to the first by forming a long linear or ramified chain. The 
polyubiquinated chains are firs recognized and degradated by a part of a proteolitic complex 
ATP-dependent called proteasome 26. This last is a proteinase of 2000 kDA formed bu a 
catalytic center, the proteasome 20S, with a molecular weight of 700 kDa. The proteasome 
20S is a multiproteic ctructure with a  cylindrical structure conaining several peptidasic 
activities and for this reason called also MPC or Multicatalytic Protease Complex. 
 
1.6.1.3 The proteasome 20S: the structure 
The proteasome of the archibacteria Thermoplasma Acidophilum is the prototype for the 
quaternary structure and the enqyme topology. It’s 28 substructures represent two omologues 
genetic products (α e β),  each of them present in 14 copies for each proteasolmal molecule 
[142, 145, 146]. 
The subunits are arranged in order to form four eptameric rings with the α subunits forming 
the two external rings and the subunits β forming the internal rings. Together thy form a 
complex with cylindrical shape, with a length of almost 15 nm and diameter of 11 nm, that 
includes the three internal cavities of 5nm of diameter delimitated by four close constrictions. 
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The central cavity is formed by two adjacent β  rings, while the two external cavities are 
delimitated by an β  and α ring. 
In the eukaryotes the subunits represent 14 genetic products, seven of them are homologues 
of the subunit α of the Thermoplasma and the other seven homologues of the β subunits. 
The relative positions of the subunits of α and β type of the eukaryotes are analogous to 
those of the proteasome in the Thermoplasma and each ring contains a complete set of the 
seven genetic products. So the proteasome is a multimeric dimmer with a symmetric axes that 
passes through the two α an β ring and their subunit are disposed in order turning the active 
sites toward the inside surface of the central channel. The ternary structure of the non catalytic 
structures α and of the catalytic ones of β type is very similar: every subunit is constituited by 
a sandwich of five antiparallel β sheets in contact with α helix 
 
Fig. 14 Structural organization of the proteasome 20S ( upper) and schematic representation of the subunit 
substitution in the immunoproteasome (below) 
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Fig. 15:  Ribbons representation of the α subunits  (A); the α helix are indicated with H, the β sheets with S. 
The helix HO at the NH2-terminal extremity represent the internal side of the proteosomal complex. In the 
barrel structure in the upper left, orientated in the same way, is indicated with a yellow sphere; (B) rapresents 
the β subunit. 
 The H1 and H2 helix mediate the interaction between the rings α and β (β-trans-α) by 
disponing in an intersecated way; the helix H3 and H4, on the other side, constituted  the 
dominant concats between the two rings β (β-transβ). Hte major difference between the 
sububits α and β is the presence of an extention N-terminal on the subunit α (α-helix-HO) that 
crosses the central sandwich. 
The N-terminal extention can be found in the upper part of the α rings, near to the entrance 
of the antechambers, and can be important for the translocation of the substrates and for the 
interaction between the proteasome and its regulatory complex. Instead of this N-terminal the 
β-subunits have a pro-sequence, of differing length, that is removed proteolitically during the 
assembling of the proteasome making freely accessible the internal cavity. Based on data 
obtained from crystallographic studies of the proteasome 20S in presence of its peptidic 
inhibitor it was concluded that the active site of the complex are found in the central chamber, 
and each subunit ha a fixed position and the interaction of the β subunits seems to be exential 
for the expression of the proteolitic activity. 
The proteasome belongs to the family of the Ntn-idrolase ( N.terminal nucleophil-idrolase): 
its catalytic center is constituited by a residue of N-terminal treonine present in β subunits that 
acts as nucleophile and as proton acceptor while other residue (Glu17, Lys33, Asp166) 
participate to the expression of the photolytic activities [144].  
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Fig. 16 :Schematic representation of the catalytic mechanism of the proteasome 20S with 
the residue of threonine that acts as nucleophile and a molecule of water that acts as base 
 
1.6.2 Proteasome 20S: the functionality 
To the complex 20s of mammalians have been attribuitedfive different peptidasic activities, 
that are distinguishable for the kind of aminoacidic  residue involved in the cleaved bond 
[144, 147, 148]. 
It’s possible to distinguish  
- the chimotripsin-like activity ( ChT-L), that cuts the carboxylic side of aromatic 
residues 
- the tripsin-like activity (T-L), that cuts prefereably the carboxylic side of basic 
aminoacid residues 
- the peptidil-glutamil-peptide idrolasic (PGPH), that cuts preferably the carboxylic side 
of acidic aminoacidic residues 
- the BrAAP (branched chain amino acid preferring) activity 
- the SNAAP ( small neutron amino acid preferring) activity 
It seems that each of this activity is associated to different β subunits, but the 
aminoterminal threonin residues have been evidenced only on 4 β subunits; so 3 of the 7 
subunits doesn’t seems to have catalytic sites.  
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Researches made with irreversible inhibitors have indicated that β subunits called X,Y and 
Z of mammalian proteasome, were associated respectively with the activity ChT-L, PGPH 
and T-L, while is not already clead if the activities BrAAp and SNAAP must be associated to 
one or more cooperating β subunits. In vitro the proteasome is not able to degradate proteic 
substrates that were already denaturated but it should have at least activation by exposition to 
heat or by low concentration of SDS or in particular ionic conditions. 
The molecular base for this activating effects is not already clear, but probably involves 
conformational changes in the proteasome ( capable of opening the central cavity towards the 
external side)  and/or allosteric modifications of the catalytic site. This mechanism doesn’t 
have a physiological significance but they can mimic the activity promoted by regulatory 
proteins, even if is not already clear if the direct activation of 20S by non proteic factors 
happens in intact cells.  
For what regards the physiological role, the complex ubiquitin-proteasome seems to be 
involved in multiple cellular functions like the growth and the division of cells, the 
degradation of regulatory cells like proto-oncogenes, the transcriptional factors and ciclines. 
It was demonstrated  that the system proteasome-ubiquitin regulates the activation of 
tsacriptional factors NF-kB, implicated in the acute and chronic inflammatory response, 
operating as promoter and process amplifier. In superior eukaryotes the proteasome is 
involved in the presentation of antigens by the major complex of hystocompatibility of class I 
(MHC I), since it degradates proteins to small peptides of about 7-10 amino acids  that once 
transferred in the endoplasmatic ring, are able to bind to MHC I  molecules giving rise to a 
complex that is then transported on the plasmatic membrane and presented to cytotoxic  
lymphocytes T that precede the cell disruption [149, 150]. On the other side it was observed 
that in certain pathological states, the cytokines are able to induce structural alteration on the 
proteasome that gains a more efficiency in the process of antigen presentation. Infact the 
induction by interpherone γ in the cell of superior eukaryotes, lead to the appearance of three 
additional  β subunits catalytically active (LMP2, MECL-1 and LMP7), that substitute 
respectively the subunit Y, Z and X of the proteasome giving rise to a complex known as 
immunoproteasome [151, 152].  The immunoproteasome differì form the original one for the 
quaternari structure and consequently for its structural function, acquiring a capacity of 
cutting more faster after hydrophobic and ramificated side chains residues  and more slowly 
after acidic residues. Between the functions of the system ubiquitin-proteasome, the 
degradation of oxidised cellular proteins is of foundamental importance, giving to proteasome 
itself a primary role in antioxidant defence mechanism, and it seems to be able to act 
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preferably at the level of hydrophobic residues that more exposed during the structural 
rearrangement of the oxidised protein. The selective degradation of damaged proteins by 
oxidation allows to the cells the regeneration of vital enzymes and proteins during normal 
aerobic life and to limitate the damage amount during situations of moderate oxidative stress. 
So the proteasome constitutes an important defense mechanism in aging process and in the 
minimization of damages related to the rising of pathologies induced by oxidation. 
 
1.6.2.1 The oxidative stress and the aging process  
During aging and the progression of some correlated pathologies, there is a generally 
diminution pf the proteolitic cell capacities. The importance of the proteolitic in order to 
maniatin the cell viability it was documented in several pathologies, including the Alzheimer 
disease, diabetes, arteriosclerosis, ischemia  damages, where the lost of cell functionality  
seems to be associated to defects in the proteolitic cellular systems.  Significateive changes  in 
the activities of this systems in function of aginig, can contribute to the cellular fragility in 
older organism respect to younger organism, potentially through an altered ability to respond 
in a proper way to pato-physiological stimuli [153-156]. Lysosomes and proteasome, that 
constitute the two main intracellular systems involved in proteic degradation, suffer 
modification of some structural and functional propertiesin function of age. 
An important role in such process is done by the presence of free radicals: 
- aging and progression of several correlated pathologies are associated to a rising in 
free radicals production and of the relative levels of oxidatie modified proteins 
- the proteins that suffer significative modifications derived from the presence of free 
radicals seems to resist to the proteolitic degradation and are able to act as inhibitors 
of the lysosomal idrolase and in proteasome; 
- the proteasome itself is capable of oxidative modifications and inactivation. 
 
1.6.2.2 The processes of reparation of oxidative damaged proteins 
After the oxidation of proteins, cells tries to repair the damaged polypeptides and recuperate 
their function: cells contain a series of proteins  capable of reconstitute the native structure of 
oxidised proteins [153]. Several shock proteins, or stress proteins, constitutive or inducible, 
are able to reconstitute the ternary proteic structure. On the other hand several enzymes are 
able to reduce the side chains  of oxidised aminoacids: 
- the system tioredoxin/tiredoxin reduces the disulphure bonds; 
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- the methionin sulphoxide reductase reduces the free sulphoxid methionins 
- the methionin sulphossid reductase peptide, reduces the oxidised forms of methionin 
contained in peptides and proteins. 
 
1.6.2.3 The degradation of oxidised proteins 
After the exposition of proteins to oxidating conditions, is possible to verify the presence of 
an higher susceptibility to the proteolitic action in several protease, that results at the highest 
level at intermediate concentrations is principally due to the rising of hydrophobicity of the 
proteic substrate after the oxidation. 
Infacts, the oxidation causes in proteins the exposition of hydrophobic portions, localized 
inside the native ternary structure, towards the exposed surface to the solvent. Since it’s 
known that proteasome prefers to binds aromatic and hydrophobic aminoacids, the recognize 
of this hydrophobic and unfolded portions by the proteasome was widely reported in literature 
[153]. It was also demonstred that an excessive oxidation causes a diminuition in the 
proteolitic susceptibility after the aggregation and the proteic cross-linking. 
It’s generally accepted that the removal of partially oxidised proteins constitutes an exential 
function for the maintaining of the cellular homeostasis and in the prevention of the 
accumulation of higly oxidised proteins and cross-linked that are no more degradable. 
Several studies have demonstrad a key role in the proteosomal system in the degradation of 
oxidised proteins: in also interesting to notice that such proteolysis, analyzed in cellular 
extracts, doesn’t results ATP dependent, while the ATP presence inhibits the degradation of 
all the oxidised in the lysate analysed. On the other hand it has been reported several effects 
of the oxidative stress on the accumulation of ubiquinated proteins and on the ubiquitinization 
system. 
It is generally accepted that the cytosolic  and nuclear proteins are generally degradated by 
the proteasome 20S by an ATP dependent mechanism, while the covalent attack of ubiquitin 
signs the protein for the ATP-dependent degradation from the proteasome 26S [153, 157, 
158]. 
 
1.6.2.4 Proteic oxidation and aging  
A significative rising in oxidised proteins it was reported in several human tissues: in 
cutaneous fibroblasts, in cheratinocites, in erythrocytes and in brains. Such rising is related to 
age and is generated by direct oxidation of the aminoacid and by the formation of proteic 
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adduct with carbohydrates and products of lypidic peroxidation [156]. The degradation of 
important enzymes and the accumulation of damaged proteins in function of aging are able to 
modify the cellular integrity. 
Infact the accumulation of oxidised proteins is associated to several pathologies like the 
formation of cataract, the Alzheimer and Parkinson disease, the lateral amyotrophic sclerosis 
and the rheumatoid arthritis [155]., In particular the progression of the Alzheimer disease  is 
associated with a defective proteolitic processing of polypeptides like the β-amyloid protein 
precursor, with conseguent formation of senile plates that bring to the neuronal degeneration. 
The Alzheimer disease is also characterized  by the accumulation of proteic forms oxidative 
modified and ubiquinated, suggesting a chain role in functionality of proteic lysosomal and 
proteosomal degradation systems [155]. The aging is correlated to a major predisposition to 
cardio hyschemic, characterized by a loss in the hemodynamic function, that provokes a rising 
in the level of oxidatively ubiquinated and modified proteins.Such observation may suggest 
that some aging processes and the rising of some pathologies related to the accumulation  of 
oxidative damaged proteins  can be partially due to a non efficient functionality of the 
proteasomal system. 
 
1.6.2.5 Degradation of the proteosomal structure and functionality during 
aging. 
Several studies have reported a diminuition in the functionality of the proteasome in 
function of age, observable in several tissutal districts [156]. Literarure reports the 
diminuition of the ChT-L activity in hearth, in kidney, in liver and in lung of animal of 
different ages. It was evidenced a diminuition of the activity of proteasome in function of age 
only in certain cerebral districts like the backbone, the hippocampus and the cerebral bark. A 
degradation of the proteosomal activity is recently demonstrated in the Parkinson and 
Alzheimer disease: such results are of particular interest since several studies have 
demonstrated have shown the inhibition of proteasome is sufficient to induce the neuronal 
death through events like the activation of the caspase, the liberation of cytochrome C, the 
high expression of p53, the fragmentation of chromatin and the opening of DNA. Moreover, 
in literature was reported the effect on proteasomal system of a dietetic ipocaloric regimen, 
the only known phenomenon capable of reduction of aging, is to maintain the PGPH activity 
in liver of older animals respect to those of young or adult rats. These evidences suggest a 
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direct implication of the modification correlated to aging with the proteosomal function in the 
turnover decline due to aging. 
 
1.6.2.6 Diminution of the expression of the proteosomal subunits 
Recent studies on the variation of the genic expression in function of aging report that the 
transcription of some genes that decode the subunits of proteasome 20S and 26S, reduces with 
age. On the other hand the caloric restriction seems to maintain, or the enhance, the genetic 
expression of the proteosomal subunits and of the activator PA28 in cells of the skeletal 
muscle of rats. Besides, the accumulation of oxidized proteins in epithelial human cells is 
associated with the diminution of the activity and of the content of proteasome , suggesting 
that the expression of the proteasome diminishes with the age. The same is described for 
human embryonic fibroblasts aged or in fibroblasts derived by donors of different age [156, 
159, 160]. 
 
1.6.2.7 Structural modifications of proteasome subunits. 
Particular attention has been applied  to studies on the effects of the oxidation on the 
proteosonal system in order to appraising the effect of the oxidation on the functionality and 
on the structure of the enzyme[156]. Several results may differ in function in the considered 
oxidation system, by the assayed proteosomal activities and by the different cells and tissues 
analyzed. Studies conducted in vitro report the inactivation or the activation of the PGPH and 
T-L components of the proteasome 20S after the oxidation metal-catalyzed in function of the 
state, activated or latent, of the enzyme. Such results show a different susceptibility of the 20S 
and 26S form to the metal-catalyzed oxidising action [161]. Other descrives the inactivation 
of the activities PGPH and T-L of the proteasome 20S in hepatic cells of rats after the 
treatment with iron-ascorbate [162]. The T-L activity is selective inactivated after treatment of 
the proteasome 20S with products of the HNE lipidic peroxidation, that damages the 
functionality of the enzyme by linking covalently to the proteasome [163, 164]. Further 
studies on proteasome 20S purified from different organs shows an inactivation correlated 
with age of several peptidasic activities and through bidimensional gel analyss, the presence 
of substitutions of the subunits and/or  of post traductional modifications that may result 
responsible of the observer diminuition of the peptidasic activity. 
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2 Materials and methods 
2.1 Materials 
2.1.1 Thrombin-polyphenol, Plasmin-polyphenol, DHFR-polyphenol, 
Proteasome 20S-polyphenol  interactions 
 
Human Thrombin (E.C.: 3.4.21.5, pdb-ID:1EB1), the synthetic substrate for 
spectrophotometric studies  tosyl-gly-pro-arg-4-nitroanilide acetate (chromozym), plasmin 
and human plasminogen (E.C.: 3.4.21.7), PMSF,  the flavonoids quesrcitin-3-rutinoside( 
rutyn) , quercitin-3-D-galactoside (hyperosyde), luteolin, ellagic acid, epicatechin, catechin 
and Tween-20, NADPH, epigallocatechingallate, dihydrofolic acid , ascorbic acid were all of 
analytical grade and obtained from sigma-Aldrich. Carboxilate cuvettes and the 
immobilization kit containing N-idroxy-succinimmide (NHS), 1-ethyll-3-(3-
dimetilaminopropyl) carbodimmide (EDC) and ethanolamine 1M, pH 8.5 were obtained from 
Affinity Sensors. . NaOH, NaCl, Tris, KCl, CaCl2, NaH2PO4, KH2PO4,  EDTA were of 
analytical grade and obtained from J.T.Baker. The experiments were conducted on a 
spectrophotometer Cary 1E from Varian Inc. Palo Alto, California, USA. The kinetic and 
thermodynamic  studies were conducted on a Iasys Plus apparatus, from Affinity Sensors, 
Cambridge UK. 
Fluorometric determinations were conducted on Shimazu RF-5301PC 
The chromatographic colum Mono-Q (HR 5/5) was obtained from Amersham Biosciences. 
 
 
2.1.2 Proteasome 20S-polyphenol  interactions 
 
Bovine brain and thyme used for the purification of proteasome 20S, were obtained from 
local butcher. The antibody direct versus subunits X,Y,LMP7 and LMP2 were from Affiniti 
Research Products Ltd. (Mamhead, Exeter, UK). The membranes necessary for the 
electotransfer were of Immobilion P kind, buyed from Millipore and for immunorevelation 
were used kits ECL Western Blotting (Amersham Biosciences). The substrates used in order 
to test the activity ChT-L, PGPH and T-L were buyed from Sigma-Aldrich (suc-LLVY-MCA 
and Z-GGL-pNA, Z-LLE-MCA and Z-LLE-2NA, Z-GGR-MCA and Z-GGR-2NA). The 
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synthetic substrate used for testing the proteolitic activity BrAAP of proteasome was kindly 
obtained from Prof. M. Orlowski (Mount Sinai MedicaI School, New York). The 
aminopeptidase-N (Ap-N) necessary for testing this particular activity was purified following 
the Pfleiderer protocol and the subsequent modifications from Almenoff [165]. Gallic acid 
and EGCG were directly dissolved in TRIS-HCl buffer 50 mM pH 8.0; resveratrol, (-)-
epicatechin and rutin were dissolved in buffer-DMSO (1:1); hyperoside, ellagic acid and 
luteolin were dissolved in DMSO. 
 
2.1.3 RP-HPLC, Folin-Ciocalteau, DPPH Assay, ORAC Assay 
 
Acetonitril, phosphoric acid, methanol, catechin, epicatechin, epigallocatechin gallate, gallic 
acid, fluorescein, AAPH, Trolox K2HPO4 and NaH2PO4 and water were all of HPLC grade  
and obtained from Sigma-Aldrich like for Folin Ciocalteau Reagent. DPPH was obtained 
from Calbiochem (Milan, Italy).  
Chromatographic column Luna C18 4,6 x 250mm was obtained from Phenomenex. 
 
2.1.4 Lipidic peroxides inhibition 
Chloroform, glacial acetic acid, potassium iodine, sodium thiosulphate potassium 
bichromate, BHT, BHA and starch paste were all obtained from Sigma 
 
 
2.2 Methods 
 
2.2.1 Accelerated Solvent Extraction: 
Extraction of polyphenols were obtained through an ASE-100 (Dionex Corp.) equipped 
with a 10 ml cell filled with approximatively 2g of grape seeds. Conditions were as following: 
pressure of 1500 psi, temperature of 150°C, 3 static cycles, flush volume 150%, purge time 
100 sec. The solvent used for the extraction was water-ethanol (50:50). After extraction the 
obtained extract is vacuum-dried and weighted. 
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2.2.2 Folin-Ciocalteau assay: 
 
Determination of polyphenols were obtained through Folin-Ciocalteau assay [166] and 
results indicated as gallic acid equivalents. Briefly standard of gallic acid from 50 to 500 mg/l 
are dissolved in water and 100 µl are pipetted in a 10 ml volumetric flask with  7,9 ml of 
water and 0,5  ml of Folin-Ciocalteau; after 30 sec and before 8 min 1,5 ml of Na2CO3  20% 
m/v is added. The solution were maintained in dark and room temperature for 2 hours and 
readings were made  on a double beam spectrophotometer at 760 nm using as blank a solution 
without gallic acid. Samples are prepared using a solution of 1mg/ml of dry extract dissolved 
in water and analyzed as indicated.  
 
2.2.3 RP-HPLC assay: 
 
Determination of gallic acid (GA), catechin (C), epicatechin (EC), epigallocatechin gallate 
(EGCG) were determined through RP-HPLC [167] using a LunaC-18 (Phenomenex) on a 
Varian Prostar HPLC system equipped with two 210  Prostar pumps and a 325 UV-VIS 
Prostar detector. A solvent gradient of 0,3% of phosphoric acid (A) and acetonitrile (B)was 
used  as indicated in table 1. The solvent flux was 1 ml/min and readings were made at 278 
nm with an injection volume of 20 µl 
 
Time 
(min) 
% B 
(H3PO4  
0.3%) 
0 10 
45 20 
65 60 
 
Tab 1: RP-HPLC gradient pattern 
 
2.2.4 DPPH Assay 
 
Antioxidant activity was measured through DPPH (1,1-diphenyl-2-picryl-hydrazyl) 
assay[168, 169].  
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In DPPH assay the odd electron of the free radical DPPH gives a strong absorption at 517 
nm and it has a violet colur. When this radicalic species cames in contact with an antioxidant, 
the odd electron pairs off with an atom of hydrogen leading to the formation of the reduced 
species  DPPH-H. This provokes a reduction of the absorbance  recorded at 517 nm and when 
the reduction is complete, there is a contemporary change of color of the sample that from 
violet to  yellow. The resultant decoloration is stoichiometric to the number of captured 
electrons. Briefly a 500 µl volume of each tested compound at various concentrations (10-5-2-
1-0,5 mg/L in methanol) was mixed with 500 µl of a 8x10-5 M of DPPH solution in 
methanol. After incubation of the mixture for 120 min, the absorbance of the remaining 
DPPH was determined colorimetrically at 517 nm. The scavenging activities were expressed 
as a percentage of the absorbance of the control DPPH solution. The results are expressed as 
mean of at least three independent experiments. Results were expressed as percentage 
activity. Mean inhibiting concentrations IC50 were calculated by use of statistical software. 
 
2.2.5 Lipidic peroxidation inhibition 
Chloroform and glacial acetic acid must be bubbled with nitrogen gas in order to make the 
solutions free from oxygen. A fresh made solution of 1% starch paste has to be made and 
must be free from iodine and iodide. The thiosulphate standardization is made with potassium 
dichromate. An appropriate amount of this standard has to be weighted in order to have a 
thiosulphate consumption (0.01 N or 0.02 N) of 45-50 ml; since dichromate has a low 
equivalent weight (MW/6) is preferable to prepare an aqueous solution  of 250 ml containing 
5 times the reactive necessary for the consumption of 40-45 ml of sodium thiosulphate and 
take each time 50 ml of this solution. 
To this 50 ml 1,5-2 g of KI must be added with 2 ml of H2SO4 2N, than the solution is 
titrated with sodium thiosulphate (0.01 N or 0.02 N) until it reaches a pale-yellow coloration. 
At this point 2-3 ml of starch paste are added as indicator and titration is made until 
disappearing of the blue coloration of the complex starchpaste-I2. 
The assay has to be made under diffused light or with artificial light. The sample has to be 
weigthed in a range between 5 and 0,5 g based on expected peroxides number. 
On appropriate flask add the sample. Add 10 ml of chloroform by dissolve the sample by 
manual shaking. Add 15 ml of acetic acid and then 1 ml of KI. Cap the solution rapidly, shake 
for 1 min and than make it stand for about 5 min, at a temperature between 15 and 25 °C. 
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Add 75 ml of distilled water. Titrate ( preferably with a  10 ml burette) the free iodine with a 
solution of thiosulphate ( 0,002 N for values less than 12 and 0,01 N for values more than 12), 
and then shake the solution using the starch paste as indicator. 
Results are expressed as numbers of peroxides (P.N.) expressed as milliequivalents of active 
oxygen/kg and is calculated by the formula: 
P.N. = (V * T / m) * 1000 
Where V is the number of ml of the standardized thiosulphate solution used in this assay, by 
taking in considerations also the blank sample; T is the exact normality of the thiosulphate 
solution used and M is the weight of the sample 
 
 
2.2.6 ORAC 
There is increasing interest in the use and measurement of antioxidant capacity in the food, 
pharmaceutical, and cosmetic industries. This interest is derived from the overwhelming 
evidence of importance of reactive oxygen/nitrogen species (ROS/RON) in aging and 
pathogenesis. Recently, Cao[170] . developed a method called oxygen radical absorbance 
capacity (ORAC), which measures antioxidant scavenging activity against peroxyl radical 
induced by 2,2’-azobis(2- amidinopropane) dihydrochloride (AAPH) at 37 °C (5, 6). In this 
assay, B-phycoerythrin (B-PE), a protein isolated from Porphyridium cruentum, was the 
chosen fluorescent probe. The loss of fluorescence of B-PE is an indication of the extent of 
damage from its reaction with the peroxyl radical. The protective effect of an antioxidant is 
measured by assessing the area under the fluorescence decay curve (AUC) of the sample as 
compared to that of the blank in which no antioxidant is present. The ORAC assay provides a 
very unique and complete assessment in which the inhibition time and inhibition degree are 
measured as the reaction goes to completion. However, the major limitation of the ORACPE 
assay[171] is the use of µ-PE as the probe. First, µ-PE produces inconsistency from lot to lot, 
which results in variable reactivity to peroxyl radical.Second, B-PE is not photostable, and 
after exposure to excitation light for certain time, it can be photobleached. This phenomenon 
was observed in a 96-well plate reader where the fluorescence signal was found to decline 
dramatically without the addition of AAPH (unpublished results). Third, it was observed that 
B-PE interacts with polyphenols due to the nonspecific protein binding. These disadvantages 
prompted us to utilize and validate a stable fluorescent probe to replace B-PE. For this reasons 
we have chosen to use fluorescein (FL) (3’,6’-dihydroxyspiro[isobenzofuran-1[3H],9’[9H]-
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xanthen]-3-one) as the fluorescent probe Unlike other popular antioxidant activity methods, 
the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking 
antioxidant capacity against peroxyl radical.  
Phosphate buffer and a fluorescein solution (FL) are preincubated at 37 °C in fluorimetric 
cuvettes before recording the initial fluorescence (f0). During each assay a blank and a 
standard must be analyzed. As blank it must be used 100 μl of buffer instead of 100 μl of 
sample. In standard case the sample must be substituted with 100 μl of a 20 μM Trolox 
solution. 
Then in the cuvette are inserted 350 μl of phosphate buffer ( 75mM, pH 7,4), 900 μl of 
fluorescein solution (0,875 μM), 100 μl of sample ( i.e. for vegetal extracts 0,2 mg/l) and 450 
μl of the AAPH solution (160mM). The reactions begins from the moment that AAPH is 
inserted. Immediately after the reaction starts the cuvette is vortexed and read immediately on 
a Shimadzu Spectrofluorimeter in order to obtain initial fluorescence value  (f0) at 493 nm 
excitation wavelength and 515 nm emission wavelength. The fluorescence is read every 5 
minutes until the fluorescence of the last reading is 5% of the initial reading. It’s important 
that the solution is maintained constantly under dark conditions, thermostated and kept under 
agitation and capped in order to prevent solvent evaporation. 
The final ORAC values were calculated by using a regression equation between the Trolox 
concentration and the net area under the FL decay curve and were expressed as Trolox 
equivalents as micromole per liter or per gram. The area under curve (AUC) was calculated as 
where f0 is the initial fluorescence reading at 0 min and fi is the fluorescence reading at time i. 
The data were analyzed by in a Microsoft Excel spreadsheet to calculate the AUC 
 
AUC =  1+ f1/f0 + f2/f0 + f3/f0 + f4/f0 + ... + f55/f0 + f60/f0.  
 
The net AUC was obtained by subtracting the AUC of the blank from that of the sample. 
The relative ORAC value (Trolox equivalents) was calculated as  
Orac Value (μM) = 20 k (AUCsample – AUCblank) / (AUCTrolox - AUCblank) 
 
where k is the dilution factor . 
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2.2.7 Spctrophotometric assay of enzymatic activity. 
The equilibrium constant of dissociation Ki of the complex  thrombin-flavonoid was 
measured by demonstrating the inhibitory effect over the amydolitic activity towards a 
chromogenic substrate [172]. 0.25 nM of human thrombin was incubated with increasing 
concentrations of flavonoid in potassium phosphate buffer 50 mM, pH 7.5 at 25°C- After 10 
minutes of preincubation ( prolonged preincubation times didn’t show an increase in 
inhibition rates), the residue activities were measured at 410 nm ( maximum of absorbance of 
the product ). The residue activity  ai was obtained by measuring the initial rates of formation 
of the product with  (V0,i) and without (V0) a certain concentration of flavonoids [I]i. 
 
o
io
i V
V
a ,=    
 
The data set was constituited by a series of residue activities ai measured at increasing 
concentrations of flavonoids  [I]i. . The constant of dissociation apparent or substrate-
dependent ( Kiapp ) was calculated for each concentration of substrate by using the standard 
Bieth equation [173] 
 
][
][1 0E
EIa −=  
The apparent constant of dissociation ( Kiapp ) is linked [173] with Ki by the equation: 
Fig. 17 : effects of Trolox concentration on FL decay curve 
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When Km ≈ Ki (like in our case), the effect of the concentration of substrate must be 
considered, by measuring the effect of increasing concentrations of substrate [173]. In our 
case, for each flavonoid studied, every set of experimental data was repeated for four 
increasing substrate concentration [S0], in the range between 1-12 μM. The fitting of 
experimental data was realizaed by the software SigmaPlot 2002 ver. 8.01 produced by SPSS 
Inc. 
 
2.2.8 Ligand immobilization. 
 
The chemistry of immobilization most commonly used in protein application is coupling 
between carboxyl groups of carboxy-methyl-dextrane and the amminic primary groups of 
proteins ( N-terminal groups and lysine), throught the EDC chemistry (1-ethyl-3-(3-
dimetinaminopropil)carbodiimmide) and NHS (N-hydroxysuccinimmide). This approach is 
also applicable to non-proteic biomolecules containing primary amminic groups. 
The electrostatic absorbance of the biomolecule on the carboxilate matrix depends on its 
concentration in solution; the level of this dependence and the interval of pH where it happens 
depends on the isoelectric point of the molecule that has to be immobilized. 
 
 
Fig. 18 Chemistry of immobilization of a macromolecule over carboxylate through EDC-HNS 
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2.2.8.1 Immobilization of thrombin over a carboxylate layer. 
The cuvette of carboxylate is inserted in the IASYS biosensor and left for equilibration for 5 
minutes at 25°C. Eventually impurities present inside of the cell of the cuvette are removed 
with washing of PBS-T (sodium phosphate 10mM, potassium chlorine 2.7 mM, sodium 
chlorine 138 mM and Tween-20 0.05% (w/w)). With the term washing we refer to a triple 
adding and removal made vary rapidly of the content of the cuvette with 75 µl of buffer. The 
binding was measured at 10 sec. The interval and the reading of the biosensor are espressed in 
arcseconds, and they correspond to the mass accumulation inside of the optical window on the 
binding layer. Every binding association was followed for 4 minutes. 
Previously to the activation of the surface, the cell is washed with PBS ( potassium 10mM 
sodium phosphate, chloride 2.7mM, 138mM sodium chloride ): in fact, the exposure of the 
surface to buffer containing cleansing agent ( like for examples Tween of the buffer PBS-t ) 
immediately before the immobilization of the ligand  it’s not advisable, from the moment that 
the level of immobilization may result reduced , maybe due to  a disguise of the reactive 
groups due to a deposit of the detergent on the surface. 
The cell is again washed with PBS for 5 min, till the obtainment  of a stable  line of base ( 
fig.5, b ). Immediately before the use, equal volumes of the solutions of EDC and of NHS are 
mixed together : this solution constitutes the mixture of activation. The PBS buffer is then  
substituted with the mixture of activation of EDC/NHS ( 7 min ) in order to activate the 
carboxylic groups on the carboxylate surface ( fig.3.4, c ). 
The mixture of activation is then removed by washing with the buffer PBS for 5 minutes ( 
fig. 5, d). The PBS is substituted with the buffer of immobilization ( acetate of 10mM sodium, 
pH 6 ) for 2 min (fig. 5, e). Finally the thrombin ( 100 G/ml, in sodium acetate) is added  and 
incubated for 10 minutes ( fig. 5, f). The ligand not immobilized is removed by washing with 
PBS ( fig. 5, g). the remaining reactive groups, are deactivated with 1M ethanolammin, pH 
8.5 ( 3 minutes.) ( fig. 5, h): this has the combinated effect to block the remaining group of the 
ester of NHS and to remove the immobilized material electrostatically. This passage is 
followed by a washing with PBS, a washing with HCl 10mM ( buffer of regeneration ) and at 
last with PBS ( fig. 5, i). Then, the reaction environment is modified to the desired pH 
(potassium phosphate buffer, pH 7.5 ) and the flavonoids are added at various concentrations. 
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Fig. 19 Immobilization of thrombin of the cabroxilate surface trhough NHS-EDC 
 
2.2.9 Studies of coagulation.  
 
The human plasma has been obtained from blood centrifugation at 1200xg for 15 min, and 
subsequently incubated with quercetin at increasing concentrations ( 0-1mM ) for 10 min at 
25°C. The time of thrombin (TT) of the plasma has been measured in accordance with a 
standard procedure [172, 174, 175] using a system STA-Rack ( Roche Diagnostics ). 
 
2.2.10 Molecular docking of the interaction thrombin-flavonoid 
The purpose of the molecular docking is that to appraise the possible geometries of bond of 
a potential ligand with a target of which is known structures you/it three-dimensional. the 
fundamental stitches of a procedure of docking are: the characterization of the site of bond, 
the positioning of the ligand in the site of bond (orienting) and the evaluation of the force of 
for the specify interaction it complex receptor-ligand [176] (scoring).  
The section for molecular docking of the MOE software ( Molecular Operating 
Environment, version 2001.01 [177] ) has been performed on a personal computer equipped 
with Intel Pentium4 processor: a docking  box of 60×40×40 points with a grid of 0 , 375 Å 
has been put around the active site of the thrombin with the flavonoid at the entrance of this. 
The annealing based on the Monte Carlo [178] method ( 6 cycles for run, 8000 iterations for 
cycle, T0=1000°K) has been simulated using the quercetin as  model. Such procedure has used 
as energy function a Merck Molecular Force Field (MMFF94) [179]. The results of the 
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docking analysis have been expressed as an set of possible complex  enzyme-ligand, ordered 
for decreasing stability.   
 
2.2.11 QSAR Analysis 
The analysis of three-dimensional QSAR has been used to draw a canonical model 
statistically meaningful and highly predictive [180]. Using the QSAR application of the MOE 
software, six descriptors  have been selected: Out of plane energy [177], Torsion energy 
[177], Molecular flexibility (calculated as index of flexibility [181]), Van der Waals acceptor 
surface area e Van der Waals donor surface area (an approximation of the sum of the surface 
VdW areas of donor and acceptor of hydrogen bonds  [182, 183]) and Molecular globularity 
(value assumed between 0 and 1, with the highest value for a perfect spherical molecule  
[184])..Then it  has been performed the QSAR-ContingencyTM e QSAR-ModelTM  using the 
pKd  as range of activities and the molecular structures of the [177] ligands . A theoretical 
value of pKd for an inhibitor is  is calculated using  the equation: 
pKd = Const + Ci ⋅ Pi
i=1
n∑  
 
Where n is the number of descriptors and Pi  is the value of the descriptor; Const  and the  
weight of the i descriptor Ci are coefficients calculated from the module QSAR-ModelTM  
[177]. 
 
2.2.12 Plasminogen purification 
The human plasminogen was irreversibly inactivated by incubation with PMSF using a 
standard procedure [185]. The resulting solution was loaded on a Mono-Q column and eluted 
at a flux of 0.5 ml/min with the following gradient of buffer C (Tris-HCl 50 mM, pH 9) and D 
(Tris-HCl 50 mM, NaCl 1 M, pH 9) 0-25% D for 8 min., 10 min. at 25% D, 25-100% D for 
20 min., 8 min. at 100% D and at the end 100-0% D for 4 min.  
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2.2.13 Spectrophotometric assay of enzymatic acticity: 
 
The dissociation equilibrium constant Kd of the complex plasmin-flavonoid have been 
determined measuring the inhibitory effect on the amidolitic activity for a [186]  chromogenic 
substrate. The human plasmin 60 nM has been incubated with increasing quantity of 
flavonoids in phosphate buffer 50 MM with NaCl 0.1M and PEG 6000 0.1 %, pH 7.5 at 25 
°C. After 10 min. of preincubation (longer times has shown no further inhibition ), the 
residual activity has been measured at 410 nm using the chromozym-PL as substrate for the 
plasmin. The residual activities have been calculated in accordance with the procedure used 
for analogous study on thrombin. 
 
2.2.14 Optical biosensor assay 
 
The cuvette of carboxylate has been washed with PBS-t ( NaH2PO4 10 mM, KCl 2.7 mM, 
NaCl 138 mM, Tween-20 0.05 % (v/v), pH 7.4 ) and equilibrated with PBS for 10 min. in 
order to obtain a stable line of base signal, at the temperature of 25 °C. The inactivated 
plasmin and plasminogen have been immobilized covalently on the matrix of carboxylate of 
the cuvette for medium using a standard  procedure of  immobilization [187]. The ligand not 
immobilized was removed by washing with PBS for 2 min. The reactive remaining groups 
were deactivated with ethanolamine 1M, which even assures that every kind of material 
electrostatically linked is removed. The immobilized quantity of plasmin and of plasminogen 
has been calculated, getting a value of 950 arcsec for both. At this conditions the partial 
mono-layer of an immobilized protein of 85 KDa results to be of 1.6 ng/mm2. Then, every 
flavonoid has been added at increasing concentrations. All the kinetics of association has been 
followed till the reaching of an equilibrium state. The dissociation and the following 
regeneration of the surface have been obtained by buffer addition. 
The binding data have been analysed using the "Fast Fit" software in endowment to the 
apparatus; this software uses an iterative fit to the curves in order to determine the observed 
growth constant and the maximum response to the equilibrium for a certain concentration of 
ligand [L]. This software uses both monoexponential and biexponential models [1, 188]. A 
standard  procedure F-test has been used then to determine which  of the two patterns resulted 
better for the fitting [189]|. Moreover,  data have been analysed globally [190, 191] using an 
monophasic curve: 
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Where the response at the equilibrium state (extent) is: 
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and Rmax  is the value of maximum concentration of the ligand. The responses measured at 
different concentrations of ligand can be simultaneously using the previous equations in order 
to determine kass, lkdiss and Rmax. 
 
 
2.2.15 Fluorometric determination 
The human plasmin 23.5 NM has been incubated with increasing quantity of flavonoids ( 5-
100 µM) in phosphate buffer 50 mM with NaCl 0.1M, pH 7.5 at 25 °C. After 10 min. of 
preincubation, the intensity of fluorescence has been measured ( emission 348 nm and 
excitation 270 nm ). The quenching constant  of Stern-Volmer KSV has been then calculated 
using the following equation: 
 
[ ] ⎟⎠⎞⎜⎝⎛ +
=
n
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Where F0  and F are the fluorescence intensity in absence and in presence of flavonoid, and 
[Q] is the concentration of the flavonoid added. Moreover the value of n indicates the kind of  
binding  stoichiometry  between the two partners. 
 
2.2.16 Molecular docking of the interaction plasmin-flavonoid.  
The molecular docking was studied on a Pentium 4 platform  using the Docking module and 
the Discover module of the InsightII software ( release 2005, Accelrys Ltd.) [176]. The 
crystallographic design of the light chain of the human plasmin 1DDJ [192]  was obtained  by 
the |protein data bank [193]. The pattern of the complex  plasmin-flavonoide has been 
optimized geometrically with the Discover module using a proper valence force field and an 
algorithm conjugated  gradients to a derived RMS of 0.001. The intermolecular energy has 
been determined in the Evaluate section of the Docking module. 
 53
 
2.2.17 Spectrophotometric determinations of DHFR activity 
The activity of the DHFR has been determinated at  25°c following the diminution of the 
absorbance of the NADPH and of the DFH at 340 nm by a spectrophotometric system Varian 
Cary 1E. 
The experiments were conducted in buffer solution containing Na2(HPO4) 50 mM, EDTA 
0.02 MM, pH 7 to 25°C. To prevent the oxidation of the catechins 1mM ascorbic acid has 
been added to the reaction mixture. The assay begins with the addition of enzyme (in absence 
of DHFR the diminution speed of of the absorbance is negligible). 
 
2.2.18 Inhibition assay 
The inhibition from EGCG has been analysed by monitoring different the different rates of 
diminuition of the absorbance of NADPH and DHF following the activation of the reaction by 
addition of DHFR, in presence of different concentrations of EGCG. The starting velocity of 
inhibition was determinated at saturating and constants concentrations of NADPH ( 100 mM ) 
and varying the concentrations of DHF ( from 5 to 50 mM ) in the mixture of reaction and of 
inhibiting EGCG ( from 0 to 50 MM ) preincubatoed with the protein at 20°c for 15 minutes. 
 
2.2.19 Purification of 20S proteasome from thymus and from bovine 
brain.  
The isolation and the purification of the complex 20S proteasome  from thymus and from 
bovine brain has been performed in accordance with an experimental protocol developed by 
Eleuteri [194], based, essentially on a cut among the 40 and 60% of ammonium sulphate, a 
ion exchange chromatography and two molecular exclusion chromatography that favour the 
removal of contaminants with low molecular weight. A greater purification rate is  obtained 
by adding a of hydrophobic interaction chromatography in order to separate  the 20S 
proteasome from the co-eluting chaperonin Hsp90. 
For the purification of the MPC from bovine modification have been used in order to 
eliominate  the phospholipidic constituents in tissues. 
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2.2.20 Determination of the proteasomal activities.  
The ChT activities-l, PGPH, t-l and BrAAP of the 20S proteasomal isolated have been 
determinated spectrophotometrically as giver-on previously 202, 203, using z-GGL-PNA, z-
LLE-2NA, z-GGR-2NA and z-GPALG-PAB, respectively, as substrate, in accordance with 
the followings she/he/it/you conditions:  
1) Cbz-Gly-Gly-Leu-PNA, concentration 0.4 MM in the assay, for the chimotripsin like 
activity; 
2) Cbz-Leu-Leu-Glu-2NA, concentration 0.64 MM in the assay, for the peptidil glutamyl-
idrolasic activity-; 
3) Cbz-Leu-Leu-argon-2NA, concentration 0.4 MM in the assay, for the tripsin-like activity 
4) Cbz-Gly-Pro-Ala-Leu-Gly-pAB, concentration 1 MM in the assay, for the BrAAP 
activity. 
The mixture of reaction was constituted by 10 µg  of enzymatic protein, the appropriate 
substrate for the activity that has to be measured ( dissolved in DMSO ) and TRIS-HCl buffer 
0.05 M until a  final volume of 250 ul. 
The samples were  incubated at  37 °C for 60 minutes and the reaction was stopped by 
addition of an equal  volume of 10 % trichloroacetic acid . The released chromophore group 
was then , measured by diazotation. For such purpose 500 µl  of a  sodium nitrite 0.1 % 
solution were added in order to  promote the formation of the diazonium salt. The sodium 
nitrite that didn’t react were came destroyed by  addition of an excess of ammonium 
sulphammate . The final reaction of copulation occurred between the salt of diazonium and N-
1-naftiletilendiammine. 
One unit of enzymatic activity was defined as the quantity of enzyme that catalyzed the 
release of 1 moles of chromophor group per hour. The specific activity is expressed in terms 
of unit for milligram of protein. 
In the case of the BrAAP activity, in order to get the aromatic amine free in solution,  it has 
to be added to the mixture of reaction an excess of Aminopeptidase N ( AP-n ). In fact, since 
the proteasome promotes the hydrolysis of the binding between  the amino acid in P2 and the 
one in  P3 of this substrate, the AP-N is necessary in order to release the p-A group-at the last 
aminoacid residue that is involved in the diaziotation. 
The chimotripsin-like activities ( ChT-L ), BrAAP and PGPH have been tested using the 
following synthetic fluorescent substrate: N-Succinil-Leu-Leu-Val-Tyr-7-amido-4-
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metilcumarina( suc-LLVY-MCA ), Cbz-Gly-Pro-Ala-Leu-Gly-pAB ( Z-GPALG-PAB ) and 
Z-Leu-Leu-Glu-MCA ( Z-LLE-MCA ) 
The isolated proteasomes were incubated with the synthetic fluorescent substrate ( 5 µM in 
this assay ) in the activity buffer ( TRIS-HCl 50 mM, pH 8.0 ): after 1h of incubation at 37°C, 
the measurement of the 7-amino-4-methyl-coumarine (AMC) and of the acid 4-aminobenzoic 
-(PABAactivity was measured  through a Shimadzu fluorimeter  RF-5301 ( AMC: λecc = 380 
nm, λem=664 nm; PABA: λecc = 304 nm, λem=664 nm). 
The specific activity using such substrates was calculated through a calibration curve 
obtained with solution of the two chromophore groups at increasing concentrations.  
The activity of proteasomes 20S were tested in presence of increasing amounts of 
antioxidants: control assays were made on order to evaluate the interference of DMSO. 
Control experiments were also done in presence of specific inhibitors of proteasome: Z-
GPFL-CHO e lactacistine (5 μM). 
 
2.2.21 Determination of IC50  
The concentration of inhibitor that cause a 50% reduction of the enzymatic activity  (IC50) 
was calculated from the equation: 
ra
IIC ][
1
1
0
50
+
=  
where ar represent the residual activity obtained at a certain concnentration of antioxidant 
related to the control in absence of the polyphenolic compound; I0 is the concentration of the 
inhibitor. The IC50 for the different polyphneolic compounds used in this present work, was 
calculated through statistical analysis software Matlab (ver. 6.5 release 13 by Mathworks Inc.) 
that allows to obtain the equation of function that best represents the ongoing of the residual 
activities obtained sperimentally, by means of increasing concentrations of antioxidants. 
In the case of the presence of low concentrations of polyphenolic substances, able to induce 
a first phase of activation of the proteolitic component of the proteasome, followed by an 
inhibition step at increasing amounts of antioxidant, the value of IC50 was obtained 
graphically taking in consideration only the inhibition phase. 
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2.2.22 Determination of the proteic concentration through Bradford 
method. 
The determination of the proteic concentration of the cellular lysates, was obtained through 
Bradford method [195]. This assay allows to determine through a spectrophotometer set at 
595 nm the absorbance of the complex that proteins made with Biorad reagent ( constituted 
by 100 mg/ml of Comassie Brilliant Blue G-250, ethnalo and phosphoric acid). Since such 
absorbance is proportional to proteic concentration, in order to know the concentration of the 
samples, is necessary to make a calibration curve  with known amounts of bovine serum 
albumine (BSA). 
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3 Experimental 
 
 
 
The main object of our research was to find a valid source of polyphenols in order to be 
used for possible nutraceutical applications. Our main attention was put towards grape seeds. 
The Marche is an Italian region with an high tradition about wine and there are several 
sources of this important raw material. 
We have identified during this research, a method in order to obtain the highest quantity of 
polyphenol with the most appropriate chemical pattern. This technology is subject of a patent 
realized by researchers of University of Camerino and gave rise to a spin-off called 
Biophenolix.  
The grape seed extracts developed by this research has several important charateritics: 
- the low catechin content 
- high concentration of proanthocyanidines 
- no degradation of active molecules during all the industrial process 
- organic origin of the raw material and possibility of obtaining the organic certification 
for all the industrial process 
This research was also financed by Italian Ministry of University and Research  
 
3.1 Characterization of Biophenolix grape seeds extract 
Biophenolix grape seed extract is a primary extract obtained by extraction with 
water:ethanol mixture (30:70). It can be used for several applications ranging from 
nutraceutical use to cosmetic and pet-food. 
The extract is characterized by a at least 28% polyphenolic content with a catechin content 
of not more than 5%.  
In table 2 is reported the comparative analysis for Biophenolix with other commercial 
available grape seed extract  
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  Biophenolix Leucoselect China 
Gallic Acid 0,83 1,01 1,1 
Epigallocatechin 
gallate 
2,50 16,03 
16,3 
Catechin 1,37 12,01 12,1 
Epicatechin 0,90 8,02 8,2 
Total monomeric 
species 
5,60 37,07 
37,7 
Purity 30,02 86,44 70,72 
ORAC µeq Trolox/gr 2000,00 6700 4600 
DPPH EC50 (mg/l) 84,04 24,01 24,28 
Tab 2: Chemical caharacteritics of grape seed extracts 
 
 
 
Fig. 20: RP-HPLC chromatogram of Biophenolix grape seed extract (GA: gallic acid; EGCG: 
epigallocatechin gallate; C: catechin; EC:epicatechin). 
 
3.2 Purification of grape seed extract on polystirenic resins 
Since Biophenolix extract has a low purity, we have developed a process capable of being 
organic certified, in order to improve the extract purity. Due to organic regulations we can use 
only water and ethanol as solvents and we have limited possibilities for the utilization of 
production coadiuvants. Polystirenic resins respond to organic regulations and are low-cost 
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and intensive use. We have tested different commercially available resisns and developed a 
method on lab scale ready to be used on a pilot-scale production. 
Extraction 
The chosen extraction solvent was ethanol at 50%. It was warmed at 55 °C; then the grape 
seeds were added. The ratio grape seeds/extraction solvent was 1/10. The experiment was 
conducted from 180 gr of grape seeds and 1800 ml of EtOH at 50%. The grape seeds were 
maintained in contact with the solvent for a period of 4 hours under magnetic stirring. Then 
the extraction was stopped and the seeds were removed  by filtration. The seeds were washed 
with 100 ml of distilled water. 
Concentration 
The extract obtained was concentrated by rotavapor under vacuum at 43 °C to remove 
ethanol. The final volume was 500 ml. Then ethanol (43,5 ml) was added to the water 
solution to rich a final concentration of 8%. Therefore we had 543,5 ml of a grape seed extract 
in ethanol at 8%. At this step we obtained, in respect with the seeds weight, yield of 8,02% for 
dry material, yield of 2,64% for polyphenols and a purity grade of 32,87%. 
Centrifugation 
The ethanolic extract was centrifugated at 3000 rpm for a period of 15 minutes. The 
supernatant had a yield of 7,03% for dry material, yield of 2,55% for polyphenols, and a 
purity grade of 36,21%. The pellet contained the 9,5% of the dry material extracted and 
2,54% of the total polyphenols extracted. The dry material and polyphenols loss was 
minimum at this step: the 87,68% of dry material and 96,63% of polyphenols remained in 
solution. 
 
The three steps were summarize in the table 3; the percentage are refered to the dry material 
and polyphenols obtained from the extraction step: 
 
  Dry mat. (g) Dry mat. (%) Polyph. (g) Polyph. (%)
Extraction  14,4343  4,744  
Supernatant 12,6567 87,68 4,5841 96,63 
Centrifugation 
Pellet 1,3751 9,53 0,1204 2,54 
Tab 3: pre-centrifugation step for chromatographic purification 
The yields of the primary extract in respect of the seeds weight were 8.02% for dry material 
and 2.64% for polyphenols. Otherwise the supernatant obtained from the centrifugation 
process had yield of 7,03% for dry material and of 2.55% for polyphenols. 
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Purification 
Loading on XAD 7-HP 
The XAD 7-HP (120 ml) was previously equilibrated with ethanol at 8%. The supernatant 
obtained from the centrifugation step was loaded on the resin. Than we wash the polymer 
with 13 column volume (CV) of ethanol at 8%. The total loading volume (LOAD 1) was 1880 
ml (15,7 CV). At this step 59,12% of dry material and 9,67% of the total polyphenols loaded 
were eluted. 
Then we made another loading step (LOAD 2)with 900 ml of ethanol at 8% (7,5 CV). The 
dry material eluted was 0,76% in absence of polyphenols. 
Elution with ethanol at 45% 
The elution step was carried out directly with ethanol at 45%. We obtained 1800 ml (15 
CV). During this phase 33,89% of dry material and 78,62% of polyphenols were recovered. 
The purity grade was 84.01%. 
 
Elution with ethanol at 70% 
This was considered the resin regeneration step. During this step we obtained 790 ml (6,6 
CV). In the course of this phase we eluted the remaining material: 6,23% of dry material and 
11,71% of the polyphenols loaded. The purity grade was 68.07%. 
The purification steps were summarize below, the percentage are refered to the dry material 
and polyphenols loaded on chromatographic column: 
 
 
Eluition 
volume (CV) 
Dry 
mat. (g) 
Dry mat. 
(%) 
Polyph. 
(g) 
Polyph. 
(%) 
Purezza 
(%) 
Load 1 15,7 7,4826 59,12 0,4433 9,67 5,92 
Load 2 7,5 0,0956 0,76 0 0,00 0,00 
EtOH 45% 15 4,2895 33,89 3,6038 78,62 84,01 
EtOH 70% 6,6 0,7889 6,23 0,537 11,71 68,07 
Tab 4: Purification steps on XAD-7HP 
The yields of the purified fraction in respect of the seeds weight were 2,38% for dry 
material and 2% for polyphenols. 
 
The product obtained after purification on XAD-7HP resins with the suggested method has 
the following characteristics: 
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  Biophenolix 
Purified 
Gallic Acid 0,15 
Epigallocatechin gallate 3,25 
Catechin 2,91 
Epicatechin 2,50 
Total monomeric species 8,80 
Purity 82,60 
ORAC µeq Trolox/gr  6313 
DPPH EC50 (mg/l) 23,54 
Tab 5: chemical characterization of purified GSE by XAD-7HP 
 
3.3 Characterization of catechins in grape seeds during ripening  
Catechins are unwanted molecules in grape seed extracts; this is due for their low 
antioxidant activity, for their possible toxic effects and for being a marker of degradation of 
raw material. Catechins are the base unit of proanthocyanidines and are found both in skin 
and seeds. Our aim was to find if there is a correlation between ripening and catechin content, 
in order to find the best ratio between catechin content and total polyphenolic content. 
We have studied the ripening of three vintages, from 2003 to 2005, by collecting grape from 
the same plant of Vitis Vinifera variety Sangiovese from a organic producer in the 
surroundings of Offida (Italy). Seeds were manually separated  and dried at 45°C for 72 
hours. The seeds where then extracted  with a water:ethanol (30:70) mixture. 
For seasons 2003 and 2004 a Soxhlet extraction was used while for 2005 accelerated solvent 
extraction was used. For 2005 vintage we have also verified the antioxidant activity using 
DPPH assay. Total polyphenolic content was determined with Folin-Ciocalteau assay and 
single catechins content through RP-HPLC assay. 
In litereature (…) is reported that during ripening there is a rising in polyphenolic content, 
until grape reaches maturation. After maturation is reached, there polyphenols decrease while 
sugars rise their concentration. Grapes are collected depending on their application: for grape 
juice is preferred to collect grapes just maturation is reached while for wine production if 
preferable to wait 10-15 days. Catechins are also responsible of sensorial properties  and the 
determination of this molecules are important in wine production . 
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Date 
TPC 
(%) GA (%) C (%) EC (%)
TM 
(%) 
21/08/03 26,67 1,99E-01 1,26E+00 4,70 6,16 
29/08/03 11,79 9,70E-02 3,84E-01 2,11 2,59 
03/09/03 19,36 1,43E-01 7,46E-01 3,36 4,25 
10/09/03 10,33 8,52E-02 3,19E-01 1,56 1,97 
18/09/03 12,16 7,74E-02 2,69E-01 1,60 1,95 
25/09/03 8,93 9,94E-02 3,49E-01 1,50 1,95 
Tab 6: Evolution of catechins during 2003 vintage. TPC: total polyphenolic content; GA: gallic acid; C: 
catechin; EC: epicatechin; TM:total monomerici content. 
 
 
 
 
 
 
 
 
Tab 7: Evolution 
of catechins during 2004 vintage. TPC: total polyphenolic content; GA: gallic acid; C: catechin; EC: 
epicatechin; TM:total monomerici content. 
 
 
ate 
TPC 
(%) 
GA 
(%) C (%) EC (%)
EGCG 
(%) 
TM 
(%) 
19/08/06 9,17 0,31 1,72 1,86 0,12 4,02 
25/08/06 10,19 0,35 1,54 2,43 0,07 4,39 
02/09/06 8,71 0,38 1,65 2,12 0,23 4,39 
13/09/06 7,73 0,28 1,16 1,33 0,52 3,30 
19/09/06 7,78 0,39 0,86 0,92 0,57 2,73 
24/09/06 7,22 0,29 0,65 0,67 0,46 2,07 
03/10/06 7,02 0,46 0,79 0,71 0,50 2,46 
Tab 8: Evolution of catechins during 2005 vintage. TPC: total polyphenolic content; GA: gallic acid; C: 
catechin; EC: epicatechin;EGCG:epigallocatechin gallate; TM:total monomeric content 
 
 
 
 
 
Date 
TPC 
(%) GA (%) C (%) EC (%) TM (%) 
24-08-2004 5,89 5,92E-02 6,90E-01 1,930308 2,679183 
09-09-2004 3,19 5,08E-02 3,47E-01 1,271279 1,668657 
23-09-2004 2,65 2,31E-02 2,23E-01 0,604663 0,850888 
30-09-2004 1,76 1,57E-02 8,50E-02 0,334728 0,435356 
07-10-2004 2,62 2,26E-03 7,29E-02 0,185819 0,261004 
14-10-2004 1,68 8,41E-03 5,83E-02 0,157347 0,224032 
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Fig. 21: Evolution of flavonoids during ripening ( AG: gallic acid, EGCG: epigallocatechingallate, 
C:catechin, EC:epicatechin, TM: total monomerici flavonoids) 
 
As is possible to observe from  tables 6, 7 and 8, absolute values are higly influenced by 
seasonability. Anyway catechin ( C, EC)  pattern follows always after reaching a maturation 
asecond order kinetic . The ratio between total polyphenols and total monomers remains 
almost the same, indicating that there isn’t a correlation between low monomerici contant and 
period of collection of grapes. This parameter is mainly influenced by other factors, like fo 
example grape variety, soil and climate conditions. The main parameter influenced during 
ripening is total polyphenolic content; for this reason in order to achieve the best yield and 
ratio of polyphenols is better to collect grape for grape seeds extract production at the very 
early stage of maturation. For this reason is also preferable to use seeds used for grape juice 
production and not those used for wine production. 
For 2005 vintage we have also evaluated the antioxidant activity and the result are presented 
in table 9 and figure 8: 
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Antioxidant activity during 2005 vintage
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Tab 9: Evolution of antioxidant activity during ripening  
 
The antioxidant activity is normalized with the percentage of polyphenols of each extract in 
order to normalize the values obtained, since the activity  depends from the polyphenolic 
content; with this normalized value it’s possible to evaluate the strength of antioxidant 
activity independently from its polyphenolic content. It’s evident that antioxidant activity is 
strictly correlated with the total polyphenolic content. Since there is no variation in the ratio 
between catechins and proanthocyanidines during ripening the antioxidant activity follows the  
same pattern of the polyphenolic content. 
Fig. 22: Evolution of antioxidant activity during ripening 
 
Date EC50 
Eq. Trolox 
Norm 
AE 
(1/EC50) 
19-ago 0,433821 0,02044 2,305098 
25-ago 0,391501 0,02229 2,554269 
02-set 0,388062 0,02097 2,576908 
13-set 0,513964 0,02028 1,945662 
19-set 0,488035 0,02028 2,049034 
24-set 0,608904 0,01944 1,642296 
03-ott 0,429916 0,02433 2,326033 
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3.4 Determination of peroxidation inhibition acitivty in lipidic 
matrix. 
 
The ability of the GSE to inhibit the lipidic peroxidation was determined in olive oil. 
Quantities of 100 and 500 ppm of GSE were added to 100 ml of olive oil and comparisons 
were made with a mixture of 50 ppm of BHT and 50 ppm BHA. Olive oil was maintained in 
dark at 45°C and peroxides were determined by titration. 
The results are indicated in table 10 and fig 9. 
 
 
Days 0 3 6 10 14 17 20 27 35 44 49
Olive Oil 1,81 5,75 5,41 2,76 4,77 3,34 6,75 27,33 69,11 134,86 176,57
GSE 100 1,81 1,68 3,27 2,71 3,48 3,22 5,88 17,60 51,66 110,03 146,77
GSE 500 1,81 1,59 4,79 2,85 3,55 3,87 4,73 24,39 64,16 128,46 168,44
BHT+BHA 1,81 2,81 3,20 2,64 4,16 4,05 5,75 11,81 21,12 39,05 51,90
 
Tab 10 : number of peroxides determined in olive oil with and without addition of antioxidants 
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Fig. 23: Number of of peroxides determined in olive oil with and without addition of antioxidants 
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3.5 Characterization of possible alternative sources of 
polyphenols 
Grape seed is not the only source of natural polyphenols. Since they are found in almost all 
vegetables we have tried to identify, based also on natural availability of possible alternative 
sources. 
3.5.1 Pomegranate 
Pomegranate is a fruit widely present in Europe and in Asia, especially in areas with  
Ripened pomegranate (Punica Granatum L. Var. Sativa K. Maly) of variety Ferdoes (A)  and 
Feyzabadwere (B) were obtained from an Iranian producer. All fruit components have been 
manually separated obtaining. Seed pomace has been manually pressed to separate the liquid 
part, called juice. The drying process has been obtained by drying at 40°C for 48 hours. All 
the components (5 g for each fruit component and variety) were then extracted in a Soxhlet 
system with 100 ml of EtOH 70% for 4 hours. The extracts were then concentrated under 
vacuum (Buchi,Switzerland) to evaporate the EtOH and finally lyophilized to remove water. 
The obtained product was used for RP-HPLC and  total polyphenolic content determination 
and enzyme inhibition studies. 
The polyphenolic content is contained in the table 11:  
 
  
Total 
Polyphenolic 
content (%) 
Ellagic 
Acid(%) 
Catechin 
(%) 
Epicatechin 
(%) 
Peel A 12,96 0,10 15,36 1,28 
Skin A 9,22 0,05 6,28 0,81 
Peel B 17,34 0,02 8,54 0,21 
Skin B 19,71 0,05 2,80 0,51 
Seeds A 1,64 0,00 N.D. N.D. 
Seeds B 0,55 0,00 N.D. N.D. 
Seeds A* 1,19 0,00 N.D. N.D. 
Seeds B* 0,55 0,00 N.D. N.D. 
Juice A N.D. 0,00 N.D. N.D. 
Juice B N.D. 0,00 0,06 N.D. 
Tab 11  : Determination of monomeric polyphenols in pomegranate Ferdoes (A)  and Feyzabadwere (B) 
variety  components  
The typical chromatogram for each fruit component is shown in following chromatogram. 
Analysis of the chromatograms shows that the main constituents of the extracts are 
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monomeric flavonoids like catechin, epicatechin and ellagic acid. Ellagic acid is the most 
present in all the constituents even if at not very high concentrations.  
 
The main flavonoid present in pomegranate is catechin which is present in peel and skin at 
high concentrations. 
Ellagic acid is present in all the components but at concentration under 0.1%. 
The species B is the richest of flavonoids at a concentration more than 4% in both skin and 
peel. 
All the extracts have a very low concentration of polymeric flavonoids, while they are rich 
in monomeric ones. 
 
Fig. 24: RP-HPLC chromatogram of typical pomegranate extract (GA: gallic acid; EA: ellagic acid; C: 
catechin; EC:epicatechin). 
 
3.5.2 Prunus Spinosa 
Prunus Spinosa is a spontaneous plant that grows in Mediterranean zone. It’s characterized 
by elevated astringency and bitter taste, that indicates the presence of polyphenols. 
Samples of prunus spinosa were collected in the Sibillini Mountains Natural Park and the 
fruit components were manually separated. Then samples were dried at 45°C for 72 hours and 
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the extraction of polyphenols was carried by Soxhlet extraction with mixture of water:ethanol 
(30:70) for 4 hours. The extracts were then concentrated under vacuum (Buchi,Switzerland) 
to evaporate the EtOH and finally lyophilized to remove water. The obtained product was 
used for RP-HPLC and  total polyphenolic content determination 
The polyphenolic and catechin content of the fruit components were investigated and the 
results are presented in the table 12 and figure 11. 
 
  
Total 
Polypnenolic 
Content (%) 
Gallic 
Acid (%) 
Catechin 
(%) 
Epicatechin 
(%) 
Fruit 0,796 0,037 5,664 0,472 
Pulp 0,504 0,014 1,820 0,235 
Skin 1,670 0,008 3,347 0,083 
Seed 0,564 0,013 0,778 0,143 
Tab 12  : determination of monomeric polyphenols in Prunus Spinosa components 
 
 
 
Fig. 25:  RP-HPLC chromatogram of typical prunus spinosa extract (GA: gallic acid;; C: catechin; 
EC:epicatechin). 
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3.5.3 Rosemary 
Rosemary (Rosmarinus officinalis)is a widely distributed plant of the Mediterranean region. 
It’s used as spice in Mediterranean diet and it’s known for it’s utilization as natural 
antioxidant. In the immediate rosemary will be recognized as natural antioxidant by EU food 
authority and it will be used in meat applications in order to prevent oxidation phenomenon. 
In this study we will consider the differences between spontaneous and cultivated rosemary, 
in order to evaluate possible differences and future applications.  
Rosemary samples were hand collected by a local Sardinian producer and dried at 45°C for 
72 hours.  
A sample of cultivated rosemary was also used to find the best extraction conditions with 
ASE in order to propose also a possible scale-up for industrial applications. 
5 g of rosemary were extracted with different mixtures of water:ethanol at different cycles 
and temperature in order to find the best extraction capabilities. The extracts were then 
concentrated under vacuum (Buchi,Switzerland) to evaporate the EtOH and finally 
lyophilized to remove water. The obtained product was used for RP-HPLC in order to 
determine  and  total polyphenolic content determination 
 The results are presented in the following tables and graphs: 
After having defined the optimal extraction parameters, we have extracted the samples with 
ASE. The results are presented in the following tables: 
 
% 
EtOH 
Dry 
Yield(%)
Polyphenols 
Yield (%) 
Purity 
(%) 
80 37,7 6,13 16,260
50 52,36 9,1 17,380
40 48,86 8,7 17,806
20 39,9 8,03 20,125
0 36,7 6,4 17,439
Tab 13  : influence of EtOH concentration on ASE extraction 
 
°C Dry Yield(%)
Polyphenols 
Yield (%) 
Purity 
(%) 
100 33,75 6,08 18,01 
150 45,36 8,14 17,95 
200 64,1 13,3 20,75 
Tab 14  : influence of temperature on ASE extraction with EtoH 50% 
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Cycles 
n° 
Dry 
Yield(%)
Polyphenols 
Yield (%) 
Purity 
(%) 
1 61,7 14,56 23,60 
2 64,3 13,26 20,62 
3 64,1 13,3 20,75 
Tab 15   : influence of number of cycles on ASE extraction with EtOH 50% and 200 °C 
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Fig. 26: influence of number of cycles on ASE extraction 
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Fig. 27: influence of ethanol concentration on ASE extraction 
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Fig. 28: influence of temperature on ASE extraction 
As is possible to observe the best water:ethanol mixture is a 50:50 ratio; even if the purity is 
not the highest available, it will be able to extract the maximum amount of polyphenols 
present in the rosemary. It would be best also to use the highest possible temperature in order 
to maximise polyphenols extraction. This is not a limitation since ASE operates in sub-critical 
conditions for the solvent using 1500 psi pressure, while in industrial applications the 
possibility of pressurize the extraction ambient is limited, and very economically non 
convenient.  The number of cycles is not influencing the extraction conditions, since one 
cycle at 200 °C with water:ethanol 50:50 is capable of extrating most of the polyphenols 
contained in rosemary. The extracts were then concentrated under vacuum 
(Buchi,Switzerland) to evaporate the EtOH and finally lyophilized to remove water. The 
obtained product was used for RP-HPLC in order to determine  and  total polyphenolic 
content determination 
After having defined the optimal extraction parameters, we have extracted the samples with 
ASE. The results are presented in the following table where the rosmarinic and carnosic acid 
are expressed as percentage of the extract obtained: 
 
  Dry Yield (%) 
Polyphenols 
Yield (%) 
Purity 
(%) 
Rosmarinic 
acid (%) 
Carnosic 
acid (%) 
Leaves cultivated 64,75 10,99 16,97 2,34 10,30 
Leaves 
Spontaneuous 61,06 11,07 18,12 2,45 9,23 
Stems cultivated 30,23 5,20 17,19 1,96 1,66 
Stems 
Spontaneous 32,60 4,48 13,75 2,29 0,89 
Tab 16   : determination of polyphenols on rosemary extracts 
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Antioxidant activity by DPPH assay was also determined and result are presented in table 
17: 
  EC50 
Equ. 
Trolox 
norm 
AE 
(1/EC50) 
Leaves cultivated 0,635426499 0,00825 1,573746 
Leaves Spontaneuous 0,992364988 0,00816 1,007694 
Stems cultivated 1,166401187 0,01287 0,857338 
Stems Spontaneous 1,148355121 0,01291 0,870811 
Tab  17   : determination of antioxidant values (DPPH assay) on rosemary extracts 
  
In order to verify the results obtained with ASE and to propose an industrial method for 
extraction of the raw material, the data obtained was used to design a 50 g scale extract 
production. 
Cultivated rosemary (leaves and stems) was dried at 45°C for 48 hours, then the dried 
material was milled.. The chosen extraction solvent was ethanol at 50%. The solvent was 
warmed at 55 °C; then dried rosemary was added. The ratio rosemary/extraction solvent was 
1/10. The experiment was conducted from 50 gr of dried rosemary and 500 ml of EtOH at 
50%. The rosemary was maintained in contact with the solvent for a period of 4 hours and 30 
minutes under magnetic stirring. Then the extraction was stopped and solid residues were 
removed by filtration. The solids were washed with 100 ml of distilled water. The extract 
obtained was concentrated at rotavapor and analyzed by Folin-Ciocalteau assay.  
The yields obtained in respect with the dried rosemary weight were: 
 
Purity (%) 25 
Dry Yield (%) 17,8
Polyphenols Yield (%) 4,5 
Tab 18   : yield of cultivated rosemary extract 
The data obtained shows that is not possible to reach values obtained by ASE; anyway the 
results obtained on the proposed process are comparable with other vegetal extracts already 
present in the market  
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3.6 Interaction Polyphenols-Thrombin  
3.6.1 Spectrophotometric tests. 
The increasing flavonoid addition to a fixed amount of thrombin has produced a range of 
isothermal inhibition hyperbolic curves, showing an increasing slope proportional to the 
decrease of the substrate concentration (Fig. 17).  These inhibition data have been analysed by 
a mathematical model 1:1 for a reversible competitive inhibition binding with the enzyme  
[173].   
 
 
Fig. 29: Inhibitory effect of some flavonoid on the amilolytic activity of thrombin: the relative activity has been 
measured at four different substrate concentrations.   
 
The substrate dependent thrombin-ligand dissociation constant, Kiap, has been obtained for 
each single studied flavonoid. Kiapp is directly related to the substrate concentration, as shown 
in the figure 17 (box) [173]. From the analysis of these values with the ⎟⎟⎠
⎞
⎜⎜⎝
⎛ +⋅=
Km
SKiKiapp
][1
0
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it is possible to calculate the  Ki* (tab. 20) and the Km. The experimental Km value, measured 
with this procedure, is 7,2 ± 0,6 µM, in agreement with previously published data [196]. 
 
3.6.2 SPR analysis 
The thrombin immobilization on the carbossilate layer has required 900 arc seconds (surface 
density 1.7 ng/mm2, equivalent to 7 mg/ml concentration). This result can be also 
qualitatively obtained from the information derived from the molecular weight of the ligand 
able to saturate the surface in a monomolecular Langmuir surface. 
The flavonoid-thrombin binding has been studied adding specific increasing concentrations 
of flavonoid in phosphate buffer and testing the association kinetics within one minute 
intervals. The dissociation has been obtained by removal of the flavonoid with buffer addition 
until the baseline attainment. As shown in the figures 19-22, monophasic association and 
dissociation kinetics have been obtained. According to the procedures described in Materials 
and Methods, it has been possible to calculate the kass, kdiss e Ki constants for each tested 
flavonoid (tab. 20), with Luteolin exception, because of the lack of detectable specific 
interaction. 
 
Fig. 30: Binding plot: association (a), dissociation (b) and partial regeneration (c) 
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Fig. 31: Association plots at different rutin concentrations 
 
Fig. 32: Association plots at different quercitin concentrations. 
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Fig. 33:  Association plots at different epicatechin concentrations. 
 
Fig. 34:  Association plots at different ellagic acid concentrations. 
 
The inhibition constants calculated with the spectrophotometric test in solution (Ki*) were in 
agreement with those calculated by the interactions on the probe surface. Such data have 
suggested an intermediate affinity binding of the flavonoids with the trombin. Among the 
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others quercitin shows the lowest inhibition constant (Ki=0.35 ± 0.04 µM, Ki*=0.23 ± 0.07 
µM). This value is similar to that one of argatroban, the powerful synthetic inhibitor 
(Ki=0,019 μM) [197]. The polyphenols having a planar structure, similar to quercitin (rutin, 
hyperoside and luteolin), show a different affinity for the human thrombin. 
This difference could be partially induced by the steric hindrance of the bulky groups of 
rutin and iperoside, partially for the impossibility for the luteolin to produce a hydrogen bond 
between the O-3, absent in this flavonoid, and the His57 of the thrombin catalytic site. This 
point can partially explain the lack of any detectable specific interaction with the trombin 
immobilised on the probe surface. The tested antocyaninidins, in particular the epicatechin 
(Ki=396 ± 128 µM, Ki*=320 ± 14 µM), form less stable complexes with the human thrombin, 
while the ellagic acid shows a quite strong inhibitory activity (Ki=7.6 ± 0.5 µM, Ki*=1.4 ± 0.5 
µM). 
The determination of the association (kass) and dissociation (kdiss) constants of the thrombin-
flavonoid binding further defines the mechanicistic properties of the process. Among the 
tested flavonoids, the trombin-quercitin bond is the kinetically favoured one (kass=1374 ± 32 
M-1s-1), while epicatechin shows the less fast kinetic (kass=17.6 ± 5.7 M-1s-1). With regard to 
the dissociation kinetic, all the tested flavonoids, with the exception of quercitin, present kdiss 
values in a narrow range (3.4 ± 0.3< kdiss <8.5 ± 0.5 ms-1). We can deduce that the 
heterogeneity of the inhibition constants is almost due to the association constant 
contribution. 
 
3.6.3 Coagulation studies 
The quercitin effect on the coagulation time has been evaluated with TT tests on human 
plasma. Quercitin ha produced a TT increase showing an anti-clotting effect at submillimolar 
concentrations (Fig.23). The minimal concentration necessary for the detection of a quercitin 
anti-clotting effect has been higher than expected, if related to the dissociation constant of the 
quercitin-thrombin complex (Kd= 0.35 μM), also because of its binding with other plasma 
proteins [172, 174, 175]. In any case the quercitin concentration range used in our work has 
been always lower than the toxicity levels of this class of compounds [198-200]. 
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Fig. 35: Quercitin anti-clotting activity: effect of increasing quercitin concentrations on plasmatic TT 
 
 
3.6.4 Extracts effect on thrombin 
As a consequence of the observed  thrombin inhibition shown by different polyphenolic 
molecules, we have tested the action of the Biophenolix grape seed extract and of other 
extracts . In figure 24 it is shown the plot of the residual thrombin activity vs. the grape seed 
extract concentration, expressed as μg of gallic acid equivalents per ml of the reaction 
mixture. 
 
Fig. 36: Residual thrombin activity vs. increasing concentrations of grape seed extract 
Such behaviour can be directly related to the monomers detected on the extract, as deduced 
from the respective inhibition constants, although the extract is particularly rich in polymeric 
species. 
The activity of other vegetal extracts have been tested and the result are shown in table 19.  
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Tab 19: Inhibition data of different extracts on thrombin 
 
3.6.5 Molecular docking 
Like the results of the inhibition constants, also the docking test has confirmed the trombin-
quercitin complex is the most stable complex. The model parameters of the complex are the 
followings: 
? Total free energy = -9.06 kcal/mole; 
? Trombin free energy = -20.33 kcal/mole; 
? Van der Waals free energy= -14.38 kcal/mole; 
As previously assumed, the model shows the presence of a 2,6 Å critical hydrogen bonding 
between the His57 of the thrombin catalytic site the O-3 of the flavonoids (Fig. 25) in 
addition to the insertion of these molecules in the narrow catalytic hydrophilic sac of this 
catalytic site (His57, Lys60f, Glu192 e Ser195). The Trp60d, the only non polar residue 
exposed in the catalytic sac, could also play a stabilising role through a hydrophobic effect. 
The crystallographic data of the argatromban-thrombin complex shows a ligand orientation 
different from the quercitin-thrombin model (Fig. 26). In effect, the argatromban molecule 
interact with the thrombin catalytic sac trough an hydrophobic packing between the quinolic 
group and the thrombin P-pocket (Tyr60a, Trp60d e His57) [201].  
 
 
 
 
 
Extract Flavonoid 
Conc.
Ki app (ug/ml)
Grape Seed 30% 6,89 ± 1,27
Green Tea 80% 11,94 ± 1,68
Seed 0,80% 340,50 ± 52,96
Skin 1,67% 450,30 ± 70,46
Peel A 12,95% 2,09 ± 0,24
Skin  A 9,22% 1,93 ± 0,24 
Peel B 17,33% 2,65 ± 0,33
Skin B 19,71% 2,670 ± 0,3579 
Prunus 
Spinosa
Pomegranate
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Name Molecular structure Ki* (µM) Ki (µM) 
kass (M-1s-1) e 
kdiss (ms-1) 
     
Quercetin 
 
0,23 ± 0,07 0,35 ± 0,04 
1374 ± 32 
0,48 ± 0,05 
Ellagic Acid 
 
1,4 ± 0,5 7,6 ± 0,5 
591 ± 4 
4,5 ± 0,3 
Luteolin 
 
10,5 ± 0,1 / / 
Hyperoside 
 
41,9 ± 0,7 38,3 ± 3,8 
87,9 ± 3,7 
3,4 ± 0,3 
Rutin 
 
58,4 ± 0,9 92,3 ± 6,8 
92,1 ± 3,2 
8,5 ± 0,5 
Catechin 
 
260 ± 12 209 ± 31 
34,5 ± 3 
7,2 ± 0,9 
Epicatechin 
 
320 ± 14 369 ± 128 
17,6 ± 5,7 
6,5 ± 0,8 
Tab 20: - Ki, kass e kdiss values obtained from the optical bioprobe; the Ki* values have been obtained from the 
spectrophotometric test.. 
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Fig. 37  :Three-dimensional docking of the thrombin-quercitin complex: the His57-quercitin hydrogen 
bonding, the catalytic triad and the residues in close contact with the flavonoids are shown  
 
 
Fig. 38: The crystallographic structure shows the argotraban-thrombin binding  (pdb-ID: 1DWC) [202]. 
 
 
3.6.6 QSAR analysis 
 
We do not have examined a high number of flavonoids; nevertheless the results of this 
analysis have been statistically significant because their inhibitory activity range cover a three 
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order size. The application of the QSAR-ContingencyTM analysis shows that only the Torsion 
energy, Molecular flexibility, Van der Waals acceptor surface area e Molecular globularity 
descriptors have been accepted for the QSAR analysis, among the six previously selected, 
because their contingency C coefficients  were > 0.6 and their Cramer V coefficients sere >0.2 
[177].  Furthermore these descriptors resulted linearly independent for the set of the examined 
flavonoids. The results of the QSAR-ModelTM are shown in the Tab. 3.2, the value of the 
constant Const = 6.49. 
 
Descriptors Extimated linear model (Cj) Relative importance 
Molecular Flexibility -1,31 1,00 
Torsion Energy +0,31 0,85 
VdW Acceptor Surface Area +0,05 0,21 
Molecular Globularity -0,69 0,03 
 
Tab 21: Results of the QSAR-ModelTM. 
 
The QSAR analysis suggests that thrombin makes stable complexes molecules having an 
high torsion energy, low flexibility, large WdW surface accepting hydrogen bonds, low 
globularity value. But, as shown in the table 21, not all these descriptors have the same 
importance. The torsion energy and the molecular flexibility are the most important 
descriptors and can determine the choice of the best thrombin inhibitor. The inhibitor must 
have an enough rigid and planar structure, a suitable WdW surface, possibly the oxygen in C-
3 accepting the hydrogen bond (as suggested fro the docking analysis). 
These results are in agreement with the previously described hypothesis: the kinetically 
limiting event is the entrance and positioning of the ligand within the thrombin catalytic sac. 
Because of its partial occlusion, the catalytic sac discriminate planar and rigid ligands. 
Quercitin and partially the ellagic acid show a more rigid and planar structure than the two 
antocyanidins, these characteristics facilitate the access within the catalytic sac, as confirmed 
from their high association constants, while luteolin is jeopardised only from the lack of the 
O-3.  
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3.7 Polyphenols-Plasmin interactions 
3.7.1 Spectrophotometric test of the enzymatic activity. 
We have measured the variation of the plasmin amilolytic activity on a chromogenic 
substrate in the presence of increasing amounts of the flavonoid and we have obtained an 
inhibition hyperbolic isotherm, whose slope decreases with the substrate concentration 
increase (Fig.3 A e C). 
 
Fig. 39:  (A, C) the relative plasmin activity vs. the flavonoid concentration measured at four different 
substrate concentrations; (B, D) the Kd, app measured for the plasmin-flavonoid interaction vs. the substrate 
concentration [S0] from which the Kd has been determined. 
 
These inhibition data can be fitted using a stechiometric model 1:1 (
⎟⎟⎠
⎞
⎜⎜⎝
⎛ +⋅=
Km
SKiKiapp
][1
0 )for the 
bonding of an enzyme with a reversible competitive enzyme [203]: this hypothesis has been 
confirmed by a Dixon plot analysis [204]. Furthermore the Kd,app , the equilibrium constant of 
the substrate dependent dissociation of the plasmin-flavonoid complex, obtained for both the 
studied flavonoids, is linearly dependent from the substrate concentration (Fig.30 B e D) 
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[203]. This result confirms the competitive type inhibition. The experimentally measured  Km 
was = 138.06 ± 7.87 µM, in accord with the literature data [205]. 
 
3.7.2 SPR studies: equilibrium analysis. 
The results of the spectrophotometric test have been confirmed with bioprobe studies. The 
Fast Fit and Global Fit analysis has shown monophasic association and dissociation kinetics 
(Fig.31 A).    
 
Fig. 40: (A) Overlapped association and dissociation curves measured at increasing quercetin concentrations; 
(B) linear relation between the quercetin concentration and the Kobs; (C)residues normalised for standard 
deviation computed for a monophasic fitting of the association data; (D) bond extent.  
 
Furthermore, the monoexponential analysis of the association curves was error-free (Fig. 31 
C) and the biexponential model does not increased the reliability of the fit on the basis of the 
F-test (95% confidence)     
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Complesso Kd* (M) Kd (M) kass (M-1s-1) e kdiss (ms-1) KSV-1 (M) 
Plasminogen-Quercetin / 7.6e-7 ± 0.8e-7 7303.33 ± 298.68 
5.6 ± 0.5 
/ 
Plasmin-Quercetin 7.15e-7 ± 0.96e-7 6.2e-7 ± 2.9e-7 6944.87 ± 1261.83 
4.3 ± 1.9 
10.35e-6 ± 1.27e-6 
Plasminogen-Rutin / 9.5e-6 ± 6.2e-6 112.76 ± 13.48 
1.1 ± 0.7 
/ 
Plasmin-Rutin 12.98e-6 ± 0.76e-6 10.7e-6 ± 0.9e-6 220.63 ± 3.73 
2.4 ± 0.2 
16.82e-6 ± 1.47 e-6 
 
 
Tab 22:  The Kd * have been calculated with spectrophotometric tests;  Kd, kass and  kdiss   have been obtained 
with the optic bioprobe;   the reciprocal value of the  Stern-Volmer KSV-1quencin constant has been calculated 
from the fluorimetric data 
 
The dissociation constants at equilibrium (Tab. 22) obtained either with spectrophotometric 
tests (Kd*) than with bioprobe studies (Kd) result comparable with each other, suggesting the 
plasmin-flavonoid complexes show a similar functional behaviour both in solution and 
immobilised on the bioprobe surface. Furthermore, the comparison of the Kd values measured 
for the complexes between the plasmin (plasminogen) and the flavonoid suggest the bonding 
site is not affected from modifications after the zymogen activation. The Kd calculated values 
(included in the range 10-6 – 10-7 M) and the saturation reached at the asymptote at high 
flavonoid concentrations suggest the presence of a specific flavonoid binding site within the 
enzyme. 
 
3.7.3 SPR studies: kinetic analysis 
The measured association (kass) and dissociation (kdiss) constants furnish further information 
concerning the mechanicistic properties of the macromolecular identification process. 
Between the two tested flavonoids, the quercitin association to plasmin and plasminogen is 
kinetically preferred to rutin (Tab. 22). The analysis of the dissociation kinetics shows similar  
kdiss for the two flavonoids. Such behaviour can explain the differences between the 
equilibrium constants simply in terms of variability in the association constants. 
 
 86 
3.7.4 Fluorimetric tests 
The measured Stern-Volmer quenching constants show the quercitin interact more 
positively with plasmin (tab. 22), as demonstrated from the faster decrease of the relative 
fluorescence intensity following the plasmin-quercitin interaction (Fig. 32). Furthermore, the 
n variable values obtained from the fitting of the experimental data with the 
[ ] ⎟⎠⎞⎜⎝⎛ +
=
n
SV QK
F
F
1
1
0
equation (1.25 ± 0.10 for quercetin and 1.08 ± 0.09 for rutin), show a 1:1 
stechiometry in the quenching process. We can suppose the plasmin-flavonoid interaction 
takes place in the catalytic site near the Trp761. 
 
Fig. 41: The Trp761 fluorescence quenching  represented as relative fluorescence intensity RFI vs. the 
quercetin ■ and rutin ▲ ( λex = 270 nm e  λem = 348 nm). 
 
 
3.7.5 Grape seed extract effect on plasmin 
Because of the inhibiting effect of the single polyphenolic compounds on plasmin, than we 
have also tested the Biophenolix grape seed extract activity. The following plot shows the 
plasmin residual activity vs. the concentration of the extract, expressed as μg of gallic acid 
equivalents per ml of the reaction mixture. 
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Fig. 3.9 – Plasmin residual activity vs. grape seed extract concentration 
 
This trend (Ki=7.572±0.660 µg/ml) can be directly related to the monomeric species of  the 
extract,  even though it is extremely rich of only partly characterised polymeric species. 
 
3.7.6 Molecular docking of the plasmin-flavonoid interaction. 
The docking has demonstrated an essentially electrostatic difference between the two 
complexes plasmin-quercetin and plasmin-rutin; a positive difference for the first complex. In 
effect, the energetic values of the complexes  (-58.4609 kcal/mol for quercetin and -52.9895 
kcal/mol for rutin) are different only because of the electrostatic contribution  (-17.6323 
kcal/mol for quercetin and -13.4532 kcal/mol for rutin).The difference is explained from the 
presence of 6 hydrogen bonds in the plasmin-quercitin complex (Trp761 and OH in position 3 
of the 2-diidroxyphenil; Arg644 and OH in position 7; Arg644 and carbonyl OH in position 4; 
Asp646 e Arg644 and carbonyl OH in position 4; Glu606 Arg644 and carbonyl OH in 
position 4; Glu606 and OH in position 3) while the plasmin-rutin complex posse 3 hydrogen 
bonds (Asp646 and OH in position 7; Arg644 and OH in position 7; His603 and OH in 
position 3 of the 2-diidroxyphenil). 
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Fig. 42: The plasmin-quercetin complex showing the catalytic triad (red) and the Trp761 responsible of the 
fluorescence emission effect. Also shows (white) the 6 hydrogen bonds 
 
Fig. 43: The plasmin-rutin complex showing the catalytic triad (red) and the Trp761 responsible of the 
fluorescence emission effect. Also shows (white) the 3 hydrogen bonds 
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3.8 Polyphenols-DHFR interactions 
3.8.1 Wt-DHFR inhibition by monomeric catechins 
The inhibition data are obtained by the contemporary pre-incubation of the catechin with the 
enzyme or by the enzyme addition to incubation mixture, containing the flavonoid and the 
substrate (DHF). The addition of increasing amounts of EGCG to a fixed wt-DHFR 
concentration produced an inhibition hyperbolic isotherm. All the experiments have been 
performed by catechin pre-incubation with the protein at different intervals. The results have 
shown a “slow-binding inhibitor” [206] trend for the EGCG and also an incubation time 
dependent inhibition. 
 
Incubation (min) % Inhibition 
0 12,15% 
5 32,56% 
10 93.57% 
15 93.5% 
Tab 23: percentage of inhibition at different incubation time of the protein with EGCG.  
[EGCG] = 100 µM, [wt-DHFR] = 40 nM, [DHF] = 30 µM. 
 
 
Fig. 44: EGCG inhibitory effect on the wt-DHFR enzymatic activity after 15 min pre-incubation (●) and 
without pre-incubation   (○). 
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All the experiments have been performed after 15 min pre-incubation of the EGCG with the 
protein; longer incubation intervals did not produced any significant variations of the residual 
activities.  
 
3.8.2  Km  determination at different EGCG concentrations. 
The  Michaelis constant (KmDHF) for the substrate has been experimentally determined 
plotting the initial speed Vi (measured when a small substrate amount has reacted) vs. 
increasing DHF concentrations. Fig. 40 shows the Michaelis curves obtained at different 
EGCG concentrations. 
 
Fig. 45:  Substrate concentration effect on the speed of the enzymatic activity, at different EGCG 
concentrations. 
●: [EGCG] = 0 μM; ▼: [EGCG] = 5 μM; ○: [EGCG] = 12,5 μM; ◊: [EGCG] = 20 μM; Δ: [EGCG] = 28,5 
μM. 
The fit of each curve has been evaluated taking in account the recently published substrate inhibition data 
[207]. 
 
The Michaelis curves analysis has shown the substrate inhibition, as recently published 
[207], and the corresponding data fit has been done with the use of the Nakano equation, 
modified for substrate inhibition. 
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where [S] stands for the substrate concentration, KmDHF indicates the Michaelis constant for 
the DHF substrate and Vmax the top speed. 
DHF
mK , Vmax and the catalytic constant kcat for each EGCG concentration have been derived 
from the data analysis (Fig. 5.7) 
 
Fig. 46 : the different plots show KmDHF, Vmax, Vmax/ KmDHF, kcat  vs. the EGCG concentration. 
 
The results clearly indicate a mixed inhibition of the EGCG on the wt-DHFR. The EGCG 
behaves both like a competitive inhibitor (the KmDHF increase with the inhibitor concentration 
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indicates a reversible competitive inhibition) and like a non competitive inhibitor (the Vmax 
decrease with the inhibitor concentration decrease indicates a non competitive inhibition). 
 
 
3.8.3 Inhibition constants determination 
In case of mixed inhibitions, the competitive (Kic) and non competitive (Kiu) inhibition 
constants can be with good approximation determined using classic analysis methods [208]. 
Plotting the reciprocal speed vs. the inhibitor concentration [I] at different substrate 
concentration, a straight lines set is obtained, intersecting each others at a coordinate point [I] 
= –Kic, as referred in [208]. Both plots allow us directly to  determine the i50, i.e. the inhibitor 
concentration producing 50% enzyme inhibition at a defined substrate concentration. If the 
S/v or 1/v  vs. I plots produce a linear relationship, i50 is the value furnished from the straight 
line intercept with the abscissa [I]. The various straight lines intercepts obtained at different 
substrate concentrations vs. [I] in the S/v or 1/v plots indicates the possible inhibition classes: 
competitive, mixed competitive, non competitive, mixed non competitive, uncompetitive 
[208]. 
The ordinate is equal to: 
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Where KmDHF e Vmax are respectively the substrate Michaelis constant and the top reaction 
speed in absence of the inhibitor. 
It has been demonstrated the EGCG-DHFR is mixed type with relevant competitive 
character (the intercept is positioned under the abscissa in an S/v vs. [I] plot, while it is 
positive in a 1/v vs. . [I] plot, Kic = 4.9 ± 1.9 μM,  Kiu = 25.0 ± 1.9 μM). In such inhibition 
type, using the S/v ratios, the i50 increases proportionally to [S]. 
 
3.8.4 Grape seed extract effect on DHFR 
After the verification of the gallate polyphenols inhibition on the DHFR, we have tried to 
test the effect of the Biophenolix grape seed extract. Unfortunately the high level of 
polymeric polyphenols has produced the DHFR aggregation ant the following precipitation, 
preventing the interaction characterization. 
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3.9 Polyphenols-Proteasome 20S interactions  
 
3.9.1 Isolation and purification of the bovine brain multicatalytic 
protease.  
In order to isolate and purify the bovine brain multicatalytic protease complex, the organ 
was previously washed in physiological solution and the external membrane was taken away, 
than the grey substance was separated from the white, contemporarily the fat and fibrous parts 
were removed. The isolated grey substance, 235 gr., was firstly homogenised with Waring-
Blendor in Tris-HCl 50 mM, KCl 150 mM, EDTA 2 mM, pH 7.5 buffer (ratio 1:2.5 
tissue/buffer).  The collected suspension was again homogenised with Potter-Elvejham. All 
the described operations were carried out at 4°C. In order to help the extraction, the 
homogenate was kept overnight in ice under mild stirring. 
After a 13500 x g centrifugation x 1h, the surnatant was added with solid ammonium 
sulphate to a 40% - 60% salt saturation. The precipitate was suspended in Tris-EDTA 50 mM 
+ KCl 150 mM, pH 8.3 buffer, and dialysed with the same buffer overnight.  Than it was 
carried out a first separation by gel-filtration on a Sephacryl S200 column, equilibrated with 
Tris-EDTA 50 mM, KCl 150 mM a pH 8.3 buffer. This step removes the higher part of 
phospholipids. The proteasome fractions were identified on the basis of their chemotropism-
like activity, than collected and concentrated by ultra filtration (YM10 membrane) under 
nitrogen atmosphere.  
The concentrated sample was loaded on a DEAE-Sephacel column, equilibrated with Tris-
EDTA 50 mM, pH 7.5 buffer and eluted in KCl (0-0.8 M) linear gradient. The active fractions 
were collected and dialysed in Tris-EDTA 50 mM, KCl 150 mM, pH 7.5 buffer, concentrated 
and loaded on a Superose 6 FPCL column. The gel-filtration eluted peak was again loaded on 
a Phenyl Sepharose CL/4B  FPLC column, equilibrated in Tris-EDTA 20 mM, (NH4)2SO4 al 
30%, pH 7.5 buffer and eluted in an ammonium sulphate (30%-0%) linear gradient.  
 
In the figure 46 are shown the results of  poliacrilammide (12%) gel electrophoresis carried 
out in denaturing conditions. The MPC characteristic electrophoretic profile is formed from 
10 protein bands showing, on the basis of a comparison with known protein markers (not 
shown), molecular weight range between 21 and 32 kDa. 
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Fig. 47 Poliacrilammide (12%) gel electrophoresis carried out in denaturing conditions, after Superose 6 
elution (lane 1) and after Phenyl Sepharose CL/4B elution (lane 2) 
 
In table 25 are collected all the quantitative date related to the bovine brain 20s proteasome 
purification steps. 
All the purification steps have been carried out at a <4° process temperature. The protein 
concentration has been measured with the Lowry method [209] for the first four steps,  and 
with the Bradford method for the following steps. The chemotropism-like activity has been 
measured according to Materials and Methods. 
 
Purification 
step  
volume 
 (ml) 
Protein 
 (mg/ml) 
Total  
activity 
Spec. act.  
(U/mg) 
recovery 
% 
Purific.
index 
homogenate 780 80.7 969.6 0.015 100 1 
surnatant 612 4.8 146.9 0.05 15.15 3.33 
 (NH4)2SO4 
precipitation 
28 14.4 30.94 0.077 3.19 5.13 
Sephacryl 
S200 
38 1.4 13.9 0.26 1.4 17.3 
DEAE-
Sephacel 
126 0.39 10.71 0.21 1.1 14 
Superose 6 5,5 0.91 1.22 0.24 0.126 16 
Phenyl 
Sepharose 
7 0.17 1.64 1.35 0.17 90 
Tab 24: Bovine brain 20s proteasome purification scheme 
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Tab. 25 shows the specific activity of the proteolytic components of the bovine brain 
purified MPC. 
Component Substrate Conc.  
(mM) 
Specfic activity 
(μmol/mg/h) 
BrAAP Z-GPALG-pAB (1.0) 1.24 
PGPH Z-LLE-2Na (0.64) 1.53 
ChT-L Z-GGL-pNA (0.4) 3.60 
T-L Z-LLR-2Na (0.4) 0.42 
SNAAP Z-GPAGG-pAB (1.0) 0.55 
Tab 25:  Bovine brain MPC proteolytic activity  
 
The proteolytic activities have been determined according to Materials and Methods. 
Figure 47 shows the immunoblotting autoradiographic film, discriminating the constitutive 
from immunogenic type of the brain enzymatic system.  
The incubation with specific antibodies  for the β, X, Y e Z subunits has shown the presence 
of  a constitutive proteasome characteristic subunits  (XYZ-MPC).  
 
 
Fig. 48: Immunorevealation of the β X, Y e Z subunits and of the 20S Core carried out on the bovine brain 
purified MPC.  The test has been performed according to Materials and Methods, the  four membrane segments 
have been incubated with primary antibodies specific for the single subunits. 
 
3.9.2 Isolation and purification of the bovine thymus multicathalytic 
protease. 
The bovine thymus protease purification procedure has been similar to that one previously 
described bovine brain isolation. In details, 270 gr. of tissue, after the accurate fat removal, 
were firstly homogenised with a Waring-Blendor in Tris-HCl 10 mM, pH 7,5 buffer, than 
centrifuged at 13500 x g per one hour.  The collected surnatant was added with 1% final 
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streptomycin solution, in order to precipitate nucleic acids and nucleo-proteins. Than it was 
carried out the fractionated precipitation with solid ammonium sulphate. The precipitate was 
obtained in the 40-60% saturation interval, it was  suspended in  Tris-EDTA 10 mM, pH 7.5 
and dialysed in the same buffer.  
 
The sample was than loaded on a DEAE-Sephacel column, equilibrated in Tris-EDTA 10 
mM, pH 7.5 buffer and eluted with a 0.01- 0.5 M  Tris-EDTA linear buffer. The next steps 
were two gel filtrations: the first on a Sephacryl S 300 column equilibrated and eluted with 
Tris-EDTA 250 mM, pH 8.3 buffer, the second on a Superose 6 equilibrated and eluted with 
Tris-EDTA 150 mM, pH 7.5 buffer. 
The figure. 48 refers the SDS electrophoresis results of the Superose 6 eluted fraction, 
exhibiting the higher chemotropism-like activity. 
 
1      2  
Fig. 49: 12% (PAGE) polyacrilamide gel electrophoresis, in denaturing conditions, before (lane1) and after 
(lane 2) the Superose 6 chromatography. The electrophoresis was carried out according to the Laemmly [61] 
procedure, as referred in Materials and Methods. 
 
Tab. 26 sows the data of the immunoproteasome purification steps, while  Tab.27 shows the 
specific activities of the five proteolytic components of the enzyme. 
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Purification  
steps 
Vol
ume 
(ml) 
Protein 
(mg/ml) 
Total 
activity 
Spec. 
Act. 
(U/mg) 
Recovery  
% 
Purific. 
index 
homogenate 104
0 
7 655 0.09 100 1 
surnatant 740 1.3 510 0.53 77.9 5.9 
 (NH4)2SO4 
precipitation 
69 2.62 257 1.42 39.2 15.8 
Sephacryl S200 222 0.50 231 2.08 35.3 23.1 
DEAE-Sephacel 61 0.90 132 2.4 20.1 26.6 
Superose 6 46 0.90 95.2 2.3 14.5 25.5 
Tab. 26– Bovine thymus MPC purification scheme 
The protein concentration has been measured with the Lowry method [209] for the first 
3steps,  and with the Bradford method for the following steps. The proteolytic activities have 
been measured according to Materials and Methods. 
 
Component Substrate conc. 
 (mM) 
Specific activity 
(μmol/mg/h)       
BrAAP Z-GPALG-pAB (1.0) 40.23            
PGPH Z-LLE-2NA (0.64) 0.80              
ChT-L Z-GGL-pNA (0.4) 1.04              
T-L Z-(D)ALR-2NA (0.4) 1.07             
SNAAP Z-GPAGG-pAB (1.0) 0.75             
Tab. 27: Thymus MPC proteolytic activities 
 
3.9.3 20S proteasome inhibition activities of polyphenolic 
compounds. 
Literature data show many ester-bond containing tea polyphenols inhibit the ChT-L activity 
of the 20S purified proteasome (Methanosarcina thermophile, Recombinant, Escherichia 
Coli). Our study shows the effect of some polyphenols on proteolytic activities of constitutive 
and γ-interferon inducible 20s proteasomes isolated respectively from bovine brain and 
thymus. Tab 28 show the IC50 values of tested antioxidants calculated from the ChT-L (Z-
GGL-pNA), PGPH (Z-LLE-2NA) BrAAP (Z-GPALG-pAB) e T-L (Z-GGR-2NA) activities: 
the data have been obtained from the fitting of the residual activity experimental data in 
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function of the antioxidant concentration, according to the equation quoted in Materials and 
Methods. 
 
 IC50 (mM) for XYZ-proteasome 
 ChT-L BrAAP PGPH T-L 
Gallic Acid 0.72 ± 0.10 13.55 ± 4.34 4.90 ± 1.09 0.27 ± 0.17 
EGCG 0.22 ± 0.06 4.3 3.4 0.06 ± 0.02 
(-)epicatechin 14.29 ±1.98 5.37 ± 1.66 NI 38.44 ± 7.01 
Luteolin 17.88 ± 8.67 2.87 ± 0.41 15.67 ± 12.00 13.62 ± 3.35 
Quercetin 3.11 ± 0.32 5.38 ± 0.84 NI 0.96 ± 0.19 
Iperoside 9.57 ± 0.88 24.97 ± 11.73 NI NI 
Rutin 7.16 ±1.42 14.60 ± 0.43 NI 6.58 ± 0.97 
Resveratrol 1.61 ± 0.49 9.24 ± 2.15 NI 10.07 ± 1.65 
Ellagic Acid 2.32 ± 0.67 14.55 ± 12.49 2.54 ± 0.30 3.26 ± 0.20 
 
 
 
 
 IC50 (mM) for LMP-proteasome 
 ChT-L BrAAP PGPH T-L 
Gallic Acid 0.71 ± 0.09 6.63 ± 0.39 5.78 ± 0.64 3.04±0.37 
EGCG 0.46 ± 0.10 0.24 ± 0.07 2.07 ± 0.31 0.24 ± 0.06 
(-)epicatechin 12.61 ± 2.14 11.56 ± 4.20 NI 13.69 ± 2.12 
Luteolin 7.26 ± 1.54 4.41 ± 0.26 7.93 ± 1.05 NI 
Quercetin 2.42 ± 0.28 1.17 ± 0.72 2.41 ± 0.60 3.60 ± 0.62 
Iperoside 6.18 ± 0.36 15.19 ± 6.91 NI NI 
Rutin 7.25 ± 0.63 35.81 ± 21.99 NI 2.65 ± 0.27 
Resveratrol 1.88 ± 0.57 9.07 ± 0.83 45.32 ± 7.04 15.79 ± 2.51 
Ellagic Acid 2.63 ± 0.24 7.20 ± 4.69 1.34 ± 0.45 NI 
Tab. 28; IC50 values obtained with the tested polyphenolic compounds and related to the ChT-L, BrAAP, 
PGPH and T-L proteasomal proteolytic components expressed from constitutive and γ-interferon inducible type 
20S proteasomes. NI (Non Inhibition) abbreviation means lack of activation or efficacy on the proteasomal 
activities of the tested compound. The activity and IC50 tests have been carried out according to Materials and 
methods. 
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Table 28 showsthe gallic acid and primarily the EGCG, in comparison with the other tested 
compounds, induce the higher inhibition of the ChT-L e T-L components of both the 
proteasome complexes. The immunoproteasomal BrAAP activity is more inhibited than the 
constitutive proteasome, while the PGPH activity is generally less affected by the tested 
compounds. The IC50 values we have obtained with EGCG result not in agreement with the 
literature data referred to the ChT-L component, expressed fro the archeobaterium 
Methanosarcina termophile 20S proteasome and tested with the fluorescent substrate Suc-
LLVY-AMC. 
 
Thereafter, with the aim to confront our data with the literature data [210-213], the activity 
tests have been carried out using fluorogenic peptides with increasing EGCG concentrations 
and with the enzymes in basal conditions or activated with SDS 0.02%. Tabs 29 show the IC50 
calculates for the two proteasomes. 
 
 IC50 (mM) for XYZ-proteasome 
 ChT-L BrAAP PGPH 
EGCG + SDS 
(0.02%) 
0.038 ± 0.004 0.017 ± 0.003 NI 
EGCG - SDS 0.14 ± 0.03 0.06 ± 0.01 0.75 ± 0.35 
 
 IC50 (mM) for LMP-proteasome 
 ChT-L BrAAP PGPH 
EGCG + SDS 
(0.02%) 
0.09 ± 0.03 0.031 ± 0.006 0.105 ± 0.008 
EGCG - SDS 0.06 ± 0.01 0.018 ± 0.003 0.033 ± 0.002 
Tab. 29: IC50 values obtained with EGCG and related to the ChT-L  proteolytic component  expressed from 
constitutive and γ-interferon inducible type 20S proteasomes. The test has been carried out with the Suc-LLVY-
AMC substrate in the presence or not of SDS. NI (Non Inhibition) abbreviation means lack of activation or 
efficacy on the proteasomal activities of the tested compound. The activity and IC50 tests have been carried out 
according to Materials and methods. 
The ChT-L activity tested with the Suc-LLVY-AMC substrate shows that the EGCG - IC50 
are lower than those obtained with the Z-GGL-pNA substrate, especially at elevated SDS 
activating concentrations. These inhibition level differences could be due to different subunits 
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composition between archeobacteria and mammal proteasomes. Furthermore, the data show 
the immunoproteasome more affected from the polyphenolic inhibiting action, with the lowest 
IC50 for the BrAAP component. 
 
3.9.4 Grape seed extract effect on the 20S proteasome functionality. 
On the basis of the observed inhibiting effect of single polyphenolic compounds on the 
isolated 20S proteasome catalytic components, we have verified the action of increasing grape 
seed extract concentrations on proteasomal functionality. The following figure sows the plot 
of the constitutive 20S proteasome ChT-L (■) and inducible γ interferon (○) activity vs. the 
grape seed extract concentration, expressed as gallic acid μg equivalents per reaction mixture 
reaction / ml. 
 
 
Fig. 50: Constitutive 20S proteasome ChT-L (■) and inducible  interferon (○) activity vs. the grape seed 
extract concentration. The activity is expressed as % of the control (without extract) 
 
With the aim to take in account the fluorescence produced from the extract components, 
each experimental point has been determined in parallel with a control sample. Both the 
enzymatic complexes show an extract concentration related inhibition. This behaviour does 
not seems directly related the monomeric polyphenolic species, because the extract is 
particularly rich in  polymeric species. 
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4 Conclusions 
4.1 Characterization of Biophenolix Grape Seed Extract 
The product obtained maintains the characteristics of low monomeric content compared to 
other commercially available grape seed extracts and the data for purity and antioxidant 
activity is comparable. The product obtained has the possibility of obtaining an organic 
certification since no organic solvents are used and the production coadiuvant used are 
included in organic legislation (EU, NOP,). The indicated process is usable also for industrial 
purpose and it’s ready for a scale-up process. 
 
4.2 Evolution of catechins in grape seeds during ripening 
The evolution of catechins during ripening follows a second order kinetic, for total 
polyphenols and single polyphenols, after reaching the maturation state. At the end of 
maturation there is a rising of polyphenols maybe due to degradation process of the fruit. The 
antioxidant activity follows the same pattern of total polyphenols. 
 
4.3 Lipidic peroxidation inhibition by GSE in oil  
The GSE added to olive oil is capable to inhibit peroxides formation even after 20 days, but 
with less activity respect to BHT and BHA mixture. This may be due also to low dissolution 
of GSE in lipidic matrix, due to the extraction conditions used for this product. GSE at 500 
ppm doesn’t have protection activity due to the possibility of acting as pro-oxidant. This 
results indicate that GSE may have a role as natural antioxidant in food applications, acting as 
protector of lipidic peroxidation by  avoiding the formation of rancidity phenomenon and 
improving shelf life of food. 
This can also suggest the utilization of GSE as natural antioxidant for example in organic 
oils, where no synthetic antioxidants can be used. 
 
4.4 Characterization of polyphenols alternative sources 
For the vegetals evaluated for possible industrial utilization for the production of extract, 
pomegranate and rosemary are the most favourable for this purpose. While pomegranate 
requires a complicated pre-extraction process, rosemary is a product ready to be used in 
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industrial applications. It’s high antioxidant activity and elevated quantity of polyphenols 
makes it a valid solution for nutraceutical applications. 
 
4.5 Polyphenols-Flavonoid interactions 
Our results clearly suggest that some flavonoids in addition to their antioxidant activity, 
essentially due to their chemical structure, may also exhibit a function in the regulation of 
some proteolytic processes, like those thrombin mediate. Furthermore the thrombinic activity 
has been inhibited from the Biophenolix grape seed extract, with inhibition constant similar to 
those of the monomeric species. A more detailed characterization of the molecular 
components of the extract and of their interaction mechanisms would be necessary for a better 
explanation of this phenomenon. 
The peculiarity of this study has been the effort to understand the molecular mechanisms of 
the polyphenols activities. Our integrated approach allows fro the first time to describe the 
flavonoid-thrombin interaction in a detailed model. We have clarified not only the kinetic and 
thermodynamic parameters but also the conformational parameters derived from structural 
bioinformatic methods (docking analysis and QSAR). It is important to point out the 
reliability of the results obtained with different experimental approaches, in accordance with 
each other. This verification suggests the possibility to use the derived information for the 
design of a mechanicistic/structural model able to describe the interaction.   
In our opinion this is perhaps the most important result derived from the present study. 
Effectively, the thermodynamic, kinetic and conformational information we have obtained 
might be used either for the study the interaction of flavonoids (used in our study or others) 
with proteolytic enzymes different from thrombin, or primarily for the design of new 
molecules, derived from flavonoids, possibly more efficient modulators of the thrombin 
mediated proteolytic processes (or mediated from other proteases), involved in many 
important physiopathologic processes. 
 
4.6 Polyphenols-Plasmin interactions 
We have characterised the thermodynamic and kinetic aspects of the interactions between 
the human plasmin and the tested flavonoids.  The 1:1 reversible complexes show dissociation 
equilibrium constant in the µM range, in particular quercetin posses the higher affinity. The 
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complexes stability (in terms of Kd) is comparable with other plasmin complexes with 
recently studied small ligands [214]. 
 
The biosensor tests have shown that the differences between the two tested flavonoids are 
primarily due to the kass, while the kdiss are essentially similar. This fact is due to the structural 
difference between the quercetin and rutin, the last one has a rutinosidic substitute in position 
3, having a larger steric hindrance. This hypothesis is confirmed from the molecular docking 
analysis: quercetin is able to place more easily itself in the catalytic sac of the enzyme, 
forming a higher number of hydrogen bonds and therefore a more stable complex. These 
flavonoids have shown a large affinity for the plasmin/plasminogen system, thus we can 
suppose their possible use in the regulation in the activities involving this system. 
Furthermore, the plasmin activity has been inhibited by the grape seed extract, perhaps 
because the monomeric polyphenols species, as confirmed from the comparable values  of the 
inhibition constants. In any case it would be necessary a more detailed characterization of the 
molecular components of the extract and of their action mechanisms. Also the explanation of 
the physiological and clinic aspects related to the modulation process would require specific 
analysis. 
 
4.7 Polyphenols-DHFR interaction 
We have studied the wt-DHFR / epigallocatechin-gallate interaction. The results show the 
EGCG behave like a mixed competitive “slow-binding inhibitor” [206] . with Kic e Kiu 
inhibition constants respectively equal to 4.9 ± 1.9 μM e 25.0 ± 1.9 μM; while the Kic is 
comparable with that one of the DHFR –Metratoxate interaction [141]. Furthermore, the 
EGCG soft character let speculate its use in the cancer prevention and treatment, showing 
highly reduced secondary effects  compared to others presently used DHFR inhibitors, like 
Metratoxate. Other in vivo studies have shown a further EGCG advantage: a different effect 
on normal and cancer cells. In effect, at physiological concentrations, the EGCG eliminates 
the cancer cells inducing apoptosis with reduced or absent effect on normal cells  [141]. 
Such different EGCG inhibition on DHFR is explained considering the higher antifolate 
compounds activity on cancer cells, generally showing an higher DNA turnover. Apoptosis 
induction can produce effective anticancer chemotherapeutic and chemiopreventive strategies. 
Many chemiopreventive agents exhibit their action for the carcinogenesis suppression by 
apoptosis induction, which eliminates specific type of cells: genetically damaged, activated or 
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advancing to carcinogenesis Therefore, the soft EGCG characteristics, joint to its power to 
induce apoptosis, produce a convincing explanation of the epidemiological data showing the 
protective effect of polyphenolgallates rich diets on specific cancer types. It is possible to 
conclude that the EGCG, polyphenolgallates and their derivates show noticeable potential 
clinic applications as anticancer agent and as antibiotic agent in the psoriasis treatment  [135, 
137, 215]. 
 
4.8  Polyphenols-Proteasome 20S interactions 
Epidemiological studies have demonstrated that a  rich in fruit and vegetables diet and a 
large use of tea and red wine result an effective prevention of some neoplastic forms. The 
anticancer effect has been ascribed to the large amount and variety of polyphenols present in 
such a kind of food. Furthermore, recent publications have shown the inhibitory effect  on 
proteolytic systems of some polyphenols present in vegetarian food and drinks like tea and 
red wine. In particular, it has been demonstrated that EGCG effectively and  selectively 
inhibits the proteasome trypsin-like component, thanks to the presence of an esteric bond 
highly susceptible to nucleophilic attack. In fact, the EGCG may form an acylic bond with the 
proteasome catalytic site at level of N-terminal threonine of the β5 subunit.  
Our results confirm the EGCG inhibitory power on the ChT-L component on isolated 
proteasomal systems either from animal organs like bovine brain and thymus, or from cellular 
lysates. Furthermore, we have demonstrated that the BrAAP is susceptible to the EGCG 
action, primarily at immunoproteasome level, normally expressing such activity in a 
preferential mode. We have also tested other polyphenolic compounds, with and without 
esteric bonds, but the inhibitory activity was lower than EGCG and essentially dependent on 
the size and hydrophobicity of the compound. 
 
Small polyphenols like the gallic acid or the Resveratrol are actually more effective, due to 
the easier penetration in the proteasomal hydrophobic channel and to the direct action on the 
catalytic site. Compounds with a larger steric hindrance and more polar, like rutin and 
iperoside, or with rigid bonds, like the ellagic acid, have a lower inhibiting activity. The 
proteasomal component more affected by the polyphenols inhibitory effect is the ChT-L for 
the constitutive proteasome and the BrAAP for the immunoproteasome. 
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The constitutive proteasomal BrAAP activity exhibit a similar IC50 to the ChT-L activity. 
With respect to the immunoproteasome some compounds result ineffective, while others show 
an higher activity than on the ChT-L component. A few polyphenolic compounds are able to 
inhibit significantly the PGPH activity. 
 
The EGCG inhibit the T-L component both in the immuno and in the XYZ-proteasome. 
Furthermore, the ChT-L component of the two proteasomal complexes show an inhibition 
directly related to the grape seed extract concentration, although it is not possibile to relate it 
directly to the polyphenolic components of the extract. It is necessary a more detailed 
characterization of the molecular components of the grape seed extract  and  of the their 
interaction mechanisms with the proteasomal complexes. 
The major interest of our study is the effort to understand the basic molecular mechanisms 
of the polyphenols effects. The scientific literature shows the possibility to prevent the cancer 
onset by the use of food with an high polyphenols content; furthermore, it has been 
evidentiated their pro-apoptotic effect selective on cancer cells and their potential use  in the 
cancer therapy synergic with chemotherapic drugs 
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